Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.3176164990111466e-58,55.89594003747658,7449.481715429609,"['RPL4', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPS6KA2', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",6.535377835095287e-56,0,0,77
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.0797703692767803e-21,8.753563001415761,416.8624351740246,"['COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1B', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'NDUFA8', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5', 'SLC25A4', 'SLC25A6']",5.157830515806415e-19,0,0,48
3,Oxidative phosphorylation WP623,4.663159385613431e-12,7.909751665657177,206.37592445678936,"['NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'ATP6AP2', 'NDUFC2', 'NDUFC1', 'ATP5F1E', 'NDUFS6', 'NDUFS5']",7.709756850880874e-10,0,0,27
4,Nonalcoholic fatty liver disease WP4396,1.9841975016235603e-10,3.658060335517316,81.72339580766068,"['CEBPA', 'NDUFA13', 'COX7B', 'GSK3A', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'LEPR', 'UQCRFS1', 'CYC1', 'COX8A', 'NDUFA8', 'XBP1', 'JUN', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",2.460404902013215e-08,0,0,44
5,Mitochondrial CIV Assembly WP4922,4.850066325206909e-09,8.998450946643718,172.26880561005936,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",4.811265794605254e-07,0,0,18
6,Glycolysis and Gluconeogenesis WP534,7.351445596531593e-07,6.9855682501503304,98.65856827051847,"['TPI1', 'GOT1', 'MDH2', 'PGAM1', 'ENO1', 'ENO2', 'GCK', 'LDHA', 'PKM', 'MPC2', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'GAPDH']",6.0771950264661174e-05,0,0,15
7,Mitochondrial complex I assembly model OXPHOS system WP4324,1.9638696393093308e-05,3.930722891566265,42.60120863012361,"['NDUFA8', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'TMEM70', 'NDUFS6', 'NDUFS5']",0.0013915419158534688,0,0,18
8,Computational Model of Aerobic Glycolysis WP4629,0.00010384627278072121,12.17773788150808,111.70150508055585,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ENO1', 'ALDOA', 'GAPDH']",0.006438468912404715,0,0,7
9,Mitochondrial complex III assembly WP4921,0.0001774830175983184,7.95551753635586,68.70890620264703,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.009781286303196215,0,0,8
10,Selenium Micronutrient Network WP15,0.0005660198175435687,3.1703383808013994,23.704244283679188,"['GPX4', 'DIO1', 'TXN', 'KMO', 'SELENOK', 'SELENOH', 'SOD1', 'SELENOM', 'PRDX5', 'SELENOS', 'RFK', 'PRDX1', 'SELENOW', 'SEPHS2', 'MSRB1']",0.02807458295016101,0,0,15
11,"GPCRs, Class A Rhodopsin-like WP455",0.0006292308686789869,2.5863378456864585,19.063928144363356,"['GPR27', 'P2RY12', 'OXTR', 'GPR12', 'P2RY14', 'GPR87', 'GPR22', 'OPRL1', 'GPR83', 'ADRA1D', 'SSTR1', 'GPR6', 'MCHR1', 'SSTR3', 'HCRTR2', 'MAS1', 'FSHR', 'GPR171', 'ACKR4', 'OR6A2']",0.028372591896797954,0,0,20
12,Glycolysis in senescence WP5049,0.0010440721091407412,8.344736842105263,57.28350351311142,"['LDHA', 'PKM', 'PGK1', 'ALDOC', 'ENO1', 'GAPDH']",0.04315498051115064,0,0,6
13,Proximal tubule transport WP4917,0.002214406242316319,3.330612138441877,20.35926920412004,"['ATP6V1G1', 'SLC22A6', 'SLC47A1', 'SLC7A9', 'SLC3A1', 'ATP1A1', 'ATP6V1E1', 'SLC22A8', 'ATP6V0C', 'ATP6V1D', 'ATP6V1F']",0.08448811509145339,0,0,11
14,Myometrial relaxation and contraction pathways WP289,0.002559589527574484,1.9960221376686267,11.912077230357113,"['RYR1', 'OXTR', 'RGS14', 'YWHAB', 'ITPR2', 'ACTG1', 'RGS4', 'GNG3', 'IGFBP6', 'YWHAG', 'CORIN', 'YWHAH', 'JUN', 'PRKCH', 'IGFBP5', 'IGFBP4', 'PRKCD', 'FOS', 'ACTA2', 'CREB3', 'PRKAR1A', 'PRKCQ', 'CALM3', 'PRKD1', 'CALM1', 'CALM2']",0.090682600405496,0,0,26
15,Cori Cycle WP1946,0.0030980972215791944,5.959501025290499,34.427841685876345,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.09687848527756027,0,0,6
16,IL-18 signaling pathway WP4754,0.003125112428308396,1.7490864799025578,10.089229339625948,"['CEBPB', 'NRN1', 'CD81', 'MEPCE', 'COX17', 'ENO1', 'ACACB', 'FUT1', 'PTMS', 'TMSB4X', 'STMN1', 'TIMP3', 'FADD', 'RPS11', 'MAPK3', 'SLC12A3', 'JUN', 'USP5', 'IMP3', 'BAD', 'PRKCD', 'NDUFC1', 'FOS', 'BPGM', 'EEF2', 'ACTA2', 'NR4A1', 'ARL4D', 'NACA', 'CYCS', 'BAX', 'NFKBIE', 'CDK5R2', 'ITM2C', 'ARF6', 'MYH7']",0.09687848527756027,0,0,36
17,VEGFA-VEGFR2 Signaling Pathway WP3888,0.0036103900536504302,1.4927194358334672,8.394963744418213,"['ARPC5L', 'SHB', 'RPL10A', 'ELK1', 'RPL7', 'HERPUD1', 'ACTG1', 'RND1', 'TUBB8', 'RPL18A', 'TMSB4X', 'CFL1', 'RPLP2', 'SH3BGRL3', 'ELOC', 'ATP6V1E1', 'RPS11', 'IER5', 'TMSB10', 'HRAS', 'HSP90AA1', 'SSR4', 'PRKCD', 'RPS6', 'RPL13A', 'EPN1', 'VAV2', 'RCN1', 'KATNAL2', 'FSCN1', 'RPL27', 'PRKD1', 'RPL26', 'ATP6V0D1', 'ALDOA', 'GAPDH', 'PTMA', 'FJX1', 'ARF6', 'SET', 'CRIP2', 'TXN', 'ACACB', 'NDRG1', 'FUT1', 'LDHA', 'PGK1', 'DNAJB9', 'FLNB', 'FADD', 'CCT7', 'MAPK3', 'EGR1', 'JUN', 'JAG1', 'SDF2L1', 'EGR3', 'DNAJA1', 'NR4A1', 'NR4A3', 'NOX4', 'CYCS', 'CALR', 'EIF4G2']",0.10533843921238902,0,0,64
18,Peptide GPCRs WP24,0.007140943330125668,3.4778443113772455,17.18719494517014,"['OXTR', 'FSHR', 'OPRL1', 'TAC4', 'SSTR1', 'SSTR3', 'TSHR', 'HCRTR2']",0.19677266065235177,0,0,8
19,Vitamin D Receptor Pathway WP2877,0.008212939493216276,2.115679022963791,10.159584565169784,"['CDKN2D', 'CEBPA', 'CDKN1A', 'CDKN1B', 'CDKN2C', 'IGFBP5', 'GADD45A', 'CDKN2A', 'CYP3A5', 'CEACAM1', 'TNFSF4', 'CREG2', 'S100A6', 'TIMP2', 'TIMP3', 'SOSTDC1', 'PRKCQ']",0.20422103053850998,0,0,17
20,Exercise-induced Circadian Regulation WP410,0.008234718973327015,2.53170359052712,12.15064819144,"['PER2', 'DNAJA1', 'DAZAP2', 'HSPA8', 'CEBPB', 'BTG1', 'GSTP1', 'STBD1', 'SUMO3', 'GFRA1', 'EIF4G2', 'HERPUD1']",0.20422103053850998,0,0,12
21,Gastrin signaling pathway WP4659,0.013946075466254529,1.8916559028674762,8.082207932098992,"['EGR1', 'JUN', 'CDKN1A', 'PRKCH', 'JAG1', 'CDKN1B', 'CDKN2A', 'BAD', 'RPS6', 'PRKCD', 'FOS', 'ELK1', 'RHOB', 'KAT5', 'PRKCQ', 'PRKD1', 'HRAS', 'MEF2D', 'MAPK3']",0.32939302053629743,0,0,19
22,Melanoma WP4685,0.015343744469157301,2.119094899665552,8.851559871621458,"['CDKN1A', 'GADD45B', 'CDKN2A', 'BAD', 'GADD45A', 'MITF', 'FOS', 'ELK1', 'BAX', 'CALM3', 'CALM1', 'HRAS', 'CALM2', 'MAPK3']",0.3459316934864555,0,0,14
23,Zinc homeostasis WP3529,0.019234957485367448,3.47488038277512,13.72934257610603,"['SLC39A11', 'SLC30A1', 'SLC39A7', 'SLC30A10', 'SLC39A1', 'SLC39A3']",0.41480603968444585,0,0,6
24,Spinal Cord Injury WP2431,0.022961697330833298,1.8883517917966917,7.126503294357475,"['EGR1', 'CDKN1B', 'GADD45A', 'XYLT1', 'MIF', 'FOS', 'RTN4', 'TNFSF13B', 'RHOB', 'SELP', 'NR4A1', 'ACAN', 'APEX1', 'NOX4', 'ROS1', 'MAPK3']",0.46159957395718415,0,0,16
25,Aryl Hydrocarbon Receptor Pathway WP2873,0.02480485777868895,2.862146653993734,10.580542662769409,"['HSP90AA1', 'JUN', 'CDKN1B', 'AIP', 'CYP1B1', 'AHRR', 'BAX']",0.46159957395718415,0,0,7
26,Complement system WP2806,0.026236878582850728,2.407106973314283,8.763287839078133,"['SELP', 'PRNP', 'FKBP2', 'RPS19', 'F12', 'CD59', 'TXN', 'CALR', 'KLKB1']",0.46159957395718415,0,0,9
27,"GPCRs, Other WP117",0.026236878582850728,2.407106973314283,8.763287839078133,"['ADGRV1', 'FSHR', 'ADGRF5', 'GPR88', 'OR2M4', 'ADRA1D', 'GPR83', 'CELSR2', 'GPR135']",0.46159957395718415,0,0,9
28,Transcriptional cascade regulating adipogenesis WP4211,0.02820681906180466,4.630027877339705,16.520826207283594,"['CEBPA', 'CEBPB', 'EGR2', 'DDIT3']",0.46159957395718415,0,0,4
29,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.02865494943544649,2.528034839412085,8.980664518162138,"['PRKCH', 'STAR', 'FSHR', 'PRKCD', 'PRKCQ', 'HRAS', 'PLCB2', 'MAPK3']",0.46159957395718415,0,0,8
30,Pathways in clear cell renal cell carcinoma WP4018,0.029389726140391318,1.8645305386135211,6.576404525671231,"['TPI1', 'BHLHE41', 'PLOD2', 'ENO1', 'ENO2', 'ACACB', 'TOX2', 'LDHA', 'PKM', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'GAPDH', 'KCNJ2']",0.46159957395718415,0,0,15
31,Cellular Proteostasis WP4918,0.02978061767465704,6.942686567164179,24.39588904581453,"['VBP1', 'PFDN5', 'PFDN6']",0.46159957395718415,0,0,3
32,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.02978061767465704,6.942686567164179,24.39588904581453,"['HSD11B1', 'HSD11B2', 'STAR']",0.46159957395718415,0,0,3
33,Apoptosis Modulation and Signaling WP1772,0.03351542712670408,1.8736131656804733,6.362320848597491,"['JUN', 'ENDOG', 'CRADD', 'CDKN2A', 'BAD', 'FOS', 'CAPNS1', 'PEA15', 'CYCS', 'BAX', 'PRKD1', 'FADD', 'BCL2L2', 'MAPK3']",0.5037470259044007,0,0,14
34,G1 to S cell cycle control WP45,0.038583053149760356,2.01329207842642,6.55314921912673,"['CDKN2D', 'CREB3', 'CDKN1A', 'CDKN1B', 'CDKN2C', 'CCNE2', 'TFDP2', 'CDKN2A', 'GADD45A', 'RPA3', 'MCM4']",0.5628586577141511,0,0,11
35,Alzheimer's disease WP2059,0.04209965113815504,1.8039084757834758,5.714269425289269,"['PSENEN', 'ATP5MD', 'BAD', 'ITPR2', 'LPL', 'CYCS', 'CALM3', 'FADD', 'CALM1', 'PLCB2', 'GAPDH', 'CALM2', 'MAPK3', 'CDK5R1']",0.5966121989864257,0,0,14
36,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.045568714908725244,2.432196289646918,7.511920629966532,"['CREB3', 'STAR', 'ITPR2', 'CALM3', 'CALM1', 'PLCB2', 'CALM2']",0.6278356276313256,0,0,7
37,HIF1A and PPARG regulation of glycolysis WP2456,0.04730009223157686,5.206567164179105,15.88650178845604,"['LDHA', 'TPI1', 'GAPDH']",0.6340769120773546,0,0,3
38,Metabolic reprogramming in colon cancer WP4290,0.04986454721585081,2.0854403834631516,6.25307830179001,"['LDHA', 'PKM', 'MDH2', 'PGAM1', 'PGK1', 'PDHB', 'ENO1', 'ALDOB', 'GAPDH']",0.6343475690723044,0,0,9
39,Senescence and Autophagy in Cancer WP615,0.05034991434322719,1.7109608351488028,5.113648501473028,"['GABARAPL2', 'GABARAPL1', 'JUN', 'CDKN1A', 'CEBPB', 'SPARC', 'CDKN1B', 'IGFBP5', 'CDKN2A', 'HMGA1', 'GABARAP', 'MAP1LC3A', 'SLC39A1', 'HRAS', 'SLC39A3']",0.6343475690723044,0,0,15
40,7q11.23 copy number variation syndrome WP4932,0.05115706202196003,1.6432537293464446,4.885154623798901,"['ATP5PB', 'ATP5MC2', 'HMGA1', 'ATP5MC3', 'UBE2L6', 'NRG1', 'ACACB', 'ATP5F1E', 'ATP5MC1', 'GRIP1', 'ATP5F1B', 'CFL1', 'BCL7B', 'EIF4H', 'WNT2', 'GAPDH', 'MAPK3']",0.6343475690723044,0,0,17
41,Galanin receptor pathway WP4970,0.054162259952484346,3.4719235364396654,10.123333697601,"['CDKN1A', 'CDKN1B', 'PRKCD', 'FOS']",0.6552312423520057,0,0,4
42,Sleep regulation WP3591,0.060594558514883115,2.4518012946805516,6.873747969416746,"['CHRNB2', 'OXTR', 'AHCY', 'STAR', 'FOS', 'HCRTR2']",0.7155928815090958,0,0,6
43,Blood Clotting Cascade WP272,0.06873910950909107,4.1648955223880595,11.151245215025229,"['F8A1', 'F12', 'KLKB1']",0.7620576601808694,0,0,3
44,Trans-sulfuration pathway WP2333,0.06873910950909107,4.1648955223880595,11.151245215025229,"['AHCY', 'GOT1', 'MAT2B']",0.7620576601808694,0,0,3
45,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.07050533210412326,1.519784110355913,4.03056919401118,"['CHRNB2', 'EGR1', 'JUN', 'CEBPB', 'TSPYL1', 'YWHAB', 'SSTR1', 'GCK', 'NEUROD1', 'ADCYAP1', 'PRKAR1A', 'BHLHE40', 'PKNOX1', 'SCN3B', 'ALDOA', 'GAPDH', 'SLC25A4', 'YWHAG', 'YWHAH']",0.7620576601808694,0,0,19
46,TP53 network WP1742,0.07067470235548386,3.0858887561396524,8.176579413815677,"['CDKN1A', 'CDKN2A', 'GADD45A', 'BAX']",0.7620576601808694,0,0,4
47,miR-517 relationship with ARCN1 and USP1 WP3596,0.08006339440794488,6.9391408114558475,17.520890107890807,"['CDKN1A', 'ARCN1']",0.8353465172131616,0,0,2
48,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.08419775538770216,1.6684753901560625,4.12878753731689,"['PSMD8', 'TUBB8', 'HSPA8', 'PSMC5', 'TUBA1A', 'PSMD7', 'TUBB2A', 'HSPA5', 'PSMD2', 'UBE2L6', 'STUB1', 'TUBA4A']",0.8353465172131616,0,0,12
49,Tryptophan metabolism WP465,0.08569740102872568,2.193339209267187,5.388887001399553,"['TDO2', 'ALDH1A1', 'CYP1B1', 'DHCR24', 'CYP2C18', 'ACMSD']",0.8353465172131616,0,0,6
50,Nuclear Receptors Meta-Pathway WP2882,0.0871680843370045,1.341045454374036,3.272039629221155,"['CDKN1B', 'SRXN1', 'GSTP1', 'AMIGO2', 'TXN', 'CYP3A5', 'FTH1', 'PRDX1', 'ENC1', 'CYP1B1', 'SLC39A7', 'SLC39A1', 'SLC39A3', 'EGR1', 'JUN', 'HSP90AA1', 'GADD45B', 'SLC6A16', 'SLC10A1', 'PLK2', 'SLC39A11', 'AIP', 'NRG1', 'SLC2A9', 'PSMC5', 'BHLHE40', 'AHRR', 'BAX', 'SPRY1', 'FKBP5', 'FTL']",0.8353465172131616,0,0,31
51,MAPK pathway in congenital thyroid cancer WP4928,0.08943844283122224,2.7770609318996415,6.7043934982495,"['JUN', 'FOS', 'ELK1', 'MAPK3']",0.8353465172131616,0,0,4
52,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.08943844283122224,2.7770609318996415,6.7043934982495,"['GSK3A', 'BAX', 'BCL2L14', 'BCL2L2']",0.8353465172131616,0,0,4
53,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.09147249987947258,1.7374100719424461,4.1553930306686615,"['FZD1', 'CDKN1A', 'JUN', 'CDKN1B', 'TMSB4X', 'NEFL', 'NEFM', 'ELK1', 'PFN2', 'SOD1']",0.8353465172131616,0,0,10
54,Translation Factors WP107,0.09147249987947258,1.7374100719424461,4.1553930306686615,"['EIF4A2', 'EEF1B2', 'EEF1G', 'EIF5', 'EIF6', 'EIF1AX', 'EIF4H', 'EEF2', 'GSPT2', 'EIF1']",0.8353465172131616,0,0,10
55,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.09372498480708949,3.4704477611940296,8.215904985847434,"['JUN', 'PRKCQ', 'MAPK3']",0.8353465172131616,0,0,3
56,Glucocorticoid Receptor Pathway WP2880,0.09481642481087107,1.7867499786013867,4.209248161291843,"['HSP90AA1', 'MGAM', 'JUN', 'GADD45B', 'PLK2', 'ENC1', 'AMIGO2', 'BHLHE40', 'SPRY1']",0.8353465172131616,0,0,9
57,Endometrial cancer WP4155,0.09711880291937634,1.6620067290889649,3.8755009922907147,"['CDKN1A', 'GADD45B', 'BAD', 'GADD45A', 'BAX', 'FOS', 'CTNNA2', 'FGF1', 'ELK1', 'HRAS', 'MAPK3']",0.8353465172131616,0,0,11
58,Aryl Hydrocarbon Receptor Netpath WP2586,0.09768164919024874,1.8526147704590818,4.309258961354936,"['CDKN1A', 'HSP90AA1', 'CDKN1B', 'AIP', 'LPL', 'CYP1B1', 'AHRR', 'HRAS']",0.8353465172131616,0,0,8
59,Pyrimidine metabolism WP4022,0.09968760447979393,1.5450053418803418,3.5623403509503566,"['NME2', 'NME1', 'POLE4', 'POLD4', 'POLE3', 'POLR2E', 'CMPK2', 'POLR3H', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'POLR2L']",0.8380517257962338,0,0,14
60,Calcium Regulation in the Cardiac Cell WP536,0.10199522175637582,1.4197090175032618,3.240953360122722,"['RYR1', 'PRKCH', 'RGS14', 'YWHAB', 'PRKCD', 'ITPR2', 'ADRA1D', 'RGS4', 'SLC8A3', 'GNG3', 'PRKAR1A', 'PRKCQ', 'CALM3', 'PRKD1', 'CALR', 'CASQ1', 'CALM1', 'CALM2', 'YWHAG', 'YWHAH']",0.8431604998527069,0,0,20
61,Kynurenine Pathway and links to Cellular Senescence WP5044,0.11031288005349298,2.524383621157815,5.5648385643680545,"['CDKN1A', 'TDO2', 'KMO', 'ACMSD']",0.8805310903285983,0,0,4
62,Adipogenesis WP236,0.11220667771570976,1.4638039141174235,3.2019433766854455,"['FZD1', 'GDF10', 'CEBPA', 'EGR2', 'CDKN1A', 'CEBPB', 'GADD45B', 'GADD45A', 'HMGA1', 'LPL', 'MIF', 'CYP26B1', 'DDIT3', 'NDN', 'SPOCK1', 'MEF2D']",0.8805310903285983,0,0,16
63,White fat cell differentiation WP4149,0.11546518836234425,2.1697549312612074,4.684036989775828,"['CEBPA', 'CEBPB', 'EGR2', 'DDIT3', 'ZNF423']",0.8805310903285983,0,0,5
64,Androgen receptor signaling pathway WP138,0.11698625940822442,1.4972078402366864,3.21255705422337,"['CDKN1A', 'JUN', 'DSTN', 'RNF6', 'PARK7', 'ETV5', 'RHOB', 'KAT5', 'PRDX1', 'BAG1', 'STUB1', 'CALR', 'FKBP4', 'RAN']",0.8805310903285983,0,0,14
65,Small cell lung cancer WP4658,0.11698625940822442,1.4972078402366864,3.21255705422337,"['CDKN1A', 'CDKN1B', 'LAMA2', 'GADD45B', 'GADD45A', 'LAMA4', 'LAMA3', 'FHIT', 'CKS1B', 'CCNE2', 'RARB', 'CYCS', 'BAX', 'SKP1']",0.8805310903285983,0,0,14
66,NRF2 pathway WP2884,0.1189859383641795,1.4687100353171343,3.126516425789229,"['EGR1', 'HSP90AA1', 'SRXN1', 'SLC6A16', 'GSTP1', 'SLC39A11', 'NRG1', 'TXN', 'SLC2A9', 'FTH1', 'PRDX1', 'SLC39A7', 'SLC39A1', 'SLC39A3', 'FTL']",0.8805310903285983,0,0,15
67,Dopaminergic Neurogenesis WP2855,0.12180421679218198,2.974413646055437,6.262152928856743,"['NEUROD1', 'ALDH1A1', 'SLC18A2']",0.8805310903285983,0,0,3
68,Breast cancer pathway WP4262,0.12242908257668293,1.406348991471504,2.9536469681650246,"['SHC4', 'FZD1', 'JUN', 'CDKN1A', 'GADD45B', 'GADD45A', 'FOS', 'FGF1', 'DLL3', 'FGF17', 'FRAT2', 'HEY1', 'BAX', 'WNT2', 'HRAS', 'SKP1', 'FGF10', 'MAPK3']",0.8805310903285983,0,0,18
69,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.12249323635619615,4.625696101829753,9.712571625363497,"['COX8A', 'GSTP1']",0.8805310903285983,0,0,2
70,Methionine De Novo and Salvage Pathway WP3580,0.1331205049432005,2.3138191955396255,4.665817585015314,"['AHCY', 'ODC1', 'TXN', 'MAT2B']",0.9432538635975348,0,0,4
71,Oncostatin M Signaling Pathway WP2374,0.13562027678075173,1.57891868323523,3.1545159229292947,"['EGR1', 'CEBPB', 'CDKN1B', 'PRKCH', 'PRKCD', 'RPS6', 'TIMP3', 'FOS', 'HRAS', 'MAPK3']",0.9474317927218712,0,0,10
72,Vitamin A and carotenoid metabolism WP716,0.15016450376238635,1.8112648221343874,3.4342013812438745,"['CYP26B1', 'RBP4', 'RBP2', 'ALDH1A1', 'LPL', 'RARB']",0.9999288470839088,0,0,6
73,Eukaryotic Transcription Initiation WP405,0.15178211468406283,1.6340965128566396,3.080777258895466,"['TAF13', 'POLR2E', 'TAF7', 'POLR3H', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.9999288470839088,0,0,8
74,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.15534225387003073,1.9283389785481835,3.5908072694218256,"['EGR2', 'RAB3A', 'NEFL', 'RABAC1', 'NDRG1']",0.9999288470839088,0,0,5
75,Pre-implantation embryo WP3527,0.15534225387003073,1.9283389785481835,3.5908072694218256,"['EGR1', 'ARGFX', 'DDIT3', 'HMGA1', 'ATP1A1']",0.9999288470839088,0,0,5
76,Nanomaterial induced apoptosis WP2507,0.15765670115147976,2.1356492969396195,3.9452605212768512,"['ENDOG', 'BAX', 'CYCS', 'FADD']",0.9999288470839088,0,0,4
77,ACE Inhibitor Pathway WP554,0.16884956876560625,3.4689737470167064,6.170426944275313,"['MAS1', 'ATP6AP2']",0.9999288470839088,0,0,2
78,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.16884956876560625,3.4689737470167064,6.170426944275313,"['CEBPB', 'ALDH1A1']",0.9999288470839088,0,0,2
79,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.16884956876560625,3.4689737470167064,6.170426944275313,"['AHCY', 'MAT2B']",0.9999288470839088,0,0,2
80,Peroxiredoxin 2 induced ovarian failure WP4873,0.16884956876560625,3.4689737470167064,6.170426944275313,"['STAR', 'BAX']",0.9999288470839088,0,0,2
81,Tamoxifen metabolism WP691,0.16884956876560625,3.4689737470167064,6.170426944275313,"['CYP1B1', 'CYP3A5']",0.9999288470839088,0,0,2
82,Base Excision Repair WP4752,0.16894782134631248,1.735645933014354,3.086265477327974,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'APEX1', 'POLE3']",0.9999288470839088,0,0,6
83,CAMKK2  Pathway WP4874,0.16894782134631248,1.735645933014354,3.086265477327974,"['FIS1', 'MAP1LC3A', 'WFS1', 'CALM1', 'CALM2', 'MAPK3']",0.9999288470839088,0,0,6
84,Photodynamic therapy-induced unfolded protein response WP3613,0.17713641282493725,1.826690156353226,3.161699529522363,"['XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR']",0.9999288470839088,0,0,5
85,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.18369867755757963,1.9829322409967571,3.359996362347705,"['H3F3B', 'H2AFZ', 'DUSP6', 'MAPK3']",0.9999288470839088,0,0,4
86,Ovarian infertility WP34,0.18369867755757963,1.9829322409967571,3.359996362347705,"['EGR1', 'CEBPB', 'CDKN1B', 'FSHR']",0.9999288470839088,0,0,4
87,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.18369867755757963,1.9829322409967571,3.359996362347705,"['JUN', 'SRXN1', 'GSTP1', 'FOS']",0.9999288470839088,0,0,4
88,Airway smooth muscle cell contraction WP4962,0.1852564522097158,2.3130348258706466,3.8998095283676353,"['RYR1', 'CALM1', 'CALM2']",0.9999288470839088,0,0,3
89,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.1852564522097158,2.3130348258706466,3.8998095283676353,"['CD63', 'CD81', 'SOD1']",0.9999288470839088,0,0,3
90,IL-5 signaling pathway WP127,0.18864993990634418,1.6660765550239234,2.7787860269888327,"['GSK3A', 'JUN', 'RPS6', 'FOS', 'ELK1', 'MAPK3']",0.9999288470839088,0,0,6
91,Oxidative Damage WP3941,0.18864993990634418,1.6660765550239234,2.7787860269888327,"['CDKN1A', 'CDKN1B', 'BAD', 'GADD45A', 'CYCS', 'NFKBIE']",0.9999288470839088,0,0,6
92,PDGF Pathway WP2526,0.1956920178847582,1.5676724387560086,2.557207964275186,"['JUN', 'ARFIP2', 'FOS', 'ELK1', 'HRAS', 'MAPK3', 'VAV2']",0.9999288470839088,0,0,7
93,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.20132392607684002,1.2635157363746026,2.02521368367137,"['SHC4', 'VAV3', 'EGR1', 'JUN', 'EGR2', 'RAB3A', 'BAD', 'RPS6', 'PRKCD', 'FOS', 'EEF2', 'ELK1', 'ACACB', 'VAV2', 'GRIP1', 'MARCKS', 'CFL1', 'HRAS', 'MAPK3', 'CDK5R1']",0.9999288470839088,0,0,20
94,Non-small cell lung cancer WP4255,0.2041088772315757,1.3889622075584882,2.207202226923622,"['CDKN1A', 'GADD45B', 'CDKN2A', 'BAD', 'GADD45A', 'RARB', 'CYCS', 'BAX', 'HRAS', 'FHIT', 'MAPK3']",0.9999288470839088,0,0,11
95,Canonical and non-canonical Notch signaling WP3845,0.2110133680324934,1.8505774591796098,2.8791909455362132,"['JAG1', 'HEY1', 'CNTN6', 'DLL3']",0.9999288470839088,0,0,4
96,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.2110133680324934,1.8505774591796098,2.8791909455362132,"['LDHA', 'RPS6', 'PDHB', 'ACACB']",0.9999288470839088,0,0,4
97,Cell cycle WP179,0.21241400820771428,1.3024654239326519,2.0178029309401406,"['CDKN2D', 'CDKN1A', 'CDKN1B', 'CDKN2C', 'GADD45B', 'GADD45A', 'YWHAB', 'CDKN2A', 'ANAPC11', 'CCNE2', 'TFDP2', 'MCM4', 'YWHAG', 'SKP1', 'YWHAH']",0.9999288470839088,0,0,15
98,Bile acids synthesis and enterohepatic circulation  WP4389,0.21746937096556831,2.7749403341288783,4.2337188686527245,"['SLC10A1', 'MAPK3']",0.9999288470839088,0,0,2
99,Dual hijack model of Vif in HIV infection WP3300,0.21746937096556831,2.7749403341288783,4.2337188686527245,"['ELOB', 'ELOC']",0.9999288470839088,0,0,2
100,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.21746937096556831,2.7749403341288783,4.2337188686527245,"['LPL', 'LDLRAP1']",0.9999288470839088,0,0,2
101,NAD Biosynthesis II (from tryptophan) WP2485,0.21746937096556831,2.7749403341288783,4.2337188686527245,"['TDO2', 'KMO']",0.9999288470839088,0,0,2
102,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.21746937096556831,2.7749403341288783,4.2337188686527245,"['ELK1', 'MEF2D']",0.9999288470839088,0,0,2
103,BMP Signaling Pathway in Eyelid Development WP3927,0.21963098227177275,2.08155223880597,3.155230401748573,"['JUN', 'MAPK3', 'FGF10']",0.9999288470839088,0,0,3
104,Type II diabetes mellitus WP1584,0.21963098227177275,2.08155223880597,3.155230401748573,"['SURF1', 'KCNJ11', 'PRKCD']",0.9999288470839088,0,0,3
105,Alpha 6 Beta 4 signaling pathway WP244,0.22378306768775053,1.652435032590442,2.4738243719986213,"['LAMA2', 'LAMA3', 'PRKCD', 'HRAS', 'MAPK3']",0.9999288470839088,0,0,5
106,Development of ureteric collection system WP5053,0.22378306768775053,1.652435032590442,2.4738243719986213,"['GRIP1', 'FRAS1', 'RARB', 'GFRA1', 'SPRY1']",0.9999288470839088,0,0,5
107,Oxidation by Cytochrome P450 WP43,0.22378306768775053,1.652435032590442,2.4738243719986213,"['CYP39A1', 'CYP26B1', 'CYP1B1', 'CYP3A5', 'CYP2C18']",0.9999288470839088,0,0,5
108,Circadian rhythm related genes WP3594,0.22499447624449762,1.2229661835748793,1.8242734960819649,"['CHRNB2', 'KLF10', 'EGR1', 'JUN', 'MAGEL2', 'EGR3', 'AHCY', 'SUV39H1', 'CIPC', 'BHLHE41', 'OPRL1', 'CARTPT', 'HCRTR2', 'HS3ST2', 'PER2', 'DBP', 'STAR', 'UBC', 'BHLHE40', 'RPS27A', 'UBA52', 'SKP1']",0.9999288470839088,0,0,22
109,Ferroptosis WP4313,0.23045431167035127,1.5423976608187135,2.2637811344519507,"['PRNP', 'MAP1LC3A', 'GPX4', 'FTH1', 'ACSL5', 'FTL']",0.9999288470839088,0,0,6
110,Parkinson's disease pathway WP2371,0.23045431167035127,1.5423976608187135,2.2637811344519507,"['PINK1', 'CCNE2', 'SYT11', 'CYCS', 'UBE2L6', 'PARK7']",0.9999288470839088,0,0,6
111,Prader-Willi and Angelman Syndrome WP3998,0.23379149382434078,1.4724081025696825,2.1398884080765788,"['OCA2', 'MAGEL2', 'CDKN2C', 'CDKN2A', 'NDN', 'GABRG3', 'GABRD']",0.9999288470839088,0,0,7
112,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.23439479736402347,1.361381483048855,1.9750220315636855,"['EGR1', 'JUN', 'CDKN1B', 'APEX1', 'RPS6', 'FOS', 'HRAS', 'TSHR', 'MYL12B', 'MAPK3']",0.9999288470839088,0,0,10
113,Gastric acid production WP2596,0.2362553530797156,6.935599284436494,10.006974319541802,['CCK'],0.9999288470839088,0,0,1
114,Nanomaterial-induced inflammasome activation WP3890,0.2362553530797156,6.935599284436494,10.006974319541802,['CTSB'],0.9999288470839088,0,0,1
115,SCFA and skeletal muscle substrate metabolism WP4030,0.2362553530797156,6.935599284436494,10.006974319541802,['PYY'],0.9999288470839088,0,0,1
116,Thyroxine (Thyroid Hormone) Production WP1981,0.2362553530797156,6.935599284436494,10.006974319541802,['TSHR'],0.9999288470839088,0,0,1
117,Complement and Coagulation Cascades WP558,0.2393642307059593,1.7347670250896057,2.480315957312412,"['SERPIND1', 'F12', 'CLU', 'KLKB1']",0.9999288470839088,0,0,4
118,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.2393642307059593,1.7347670250896057,2.480315957312412,"['GOT1', 'MDH2', 'SCO2', 'HMGA1']",0.9999288470839088,0,0,4
119,Prostaglandin Synthesis and Regulation WP98,0.2483544328532808,1.5771885018746943,2.1968633224171317,"['HSD11B1', 'HSD11B2', 'S100A6', 'MITF', 'PTGES']",0.9999288470839088,0,0,5
120,Prolactin Signaling Pathway WP2037,0.2503369872044112,1.3350857775318208,1.8490234695223386,"['JUN', 'RPS6KA2', 'RPS6', 'FOS', 'ELK1', 'CTSD', 'HRAS', 'YWHAG', 'VAV2', 'MAPK3']",0.9999288470839088,0,0,10
121,Proteasome Degradation WP183,0.25221474687598,1.358194180321463,1.8708776921878156,"['PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'PSMD2', 'UBC', 'PSME1', 'PSMB10']",0.9999288470839088,0,0,9
122,Genotoxicity pathway WP4286,0.2534507392819761,1.3882634730538923,1.905510725875605,"['ACTA2', 'PLK3', 'CDKN1A', 'RPS27', 'GADD45A', 'PCDH8', 'TRIAP1', 'TRIM22']",0.9999288470839088,0,0,8
123,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.2534507392819761,1.3882634730538923,1.905510725875605,"['IFI27L2', 'JUN', 'PRKCH', 'PRKCD', 'PRKCQ', 'HRAS', 'PLCB2', 'MAPK3']",0.9999288470839088,0,0,8
124,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.2536989147577286,1.4289787728376808,1.9599974163490692,"['CDKN1A', 'HSP90AA1', 'JUN', 'CDKN2A', 'BAX', 'FOS', 'ELK1']",0.9999288470839088,0,0,7
125,Differentiation of white and brown adipocyte WP2895,0.2551380398180508,1.892157394843962,2.5845934297678843,"['CEBPA', 'CEBPB', 'ZNF423']",0.9999288470839088,0,0,3
126,Imatinib and Chronic Myeloid Leukemia WP3640,0.2551380398180508,1.892157394843962,2.5845934297678843,"['SPRED2', 'CDKN1B', 'GADD45A']",0.9999288470839088,0,0,3
127,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.2670461272962749,2.3122513922036596,3.0529438385478542,"['JAG1', 'WNT2']",0.9999288470839088,0,0,2
128,Farnesoid X receptor pathway WP2879,0.2670461272962749,2.3122513922036596,3.0529438385478542,"['SLC10A1', 'FKBP5']",0.9999288470839088,0,0,2
129,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.2670461272962749,2.3122513922036596,3.0529438385478542,"['ELOB', 'ELOC']",0.9999288470839088,0,0,2
130,PDGFR-beta pathway WP3972,0.2735660841525185,1.5084851477429246,1.95531664437786,"['JUN', 'FOS', 'ELK1', 'HRAS', 'MAPK3']",0.9999288470839088,0,0,5
131,TNF-alpha signaling pathway WP231,0.27476873761353166,1.2622503546873294,1.630607181998016,"['HSP90AA1', 'JUN', 'BAD', 'PSMD2', 'RFK', 'BAX', 'TXN', 'FADD', 'NFKBIE', 'HRAS', 'SKP1', 'MAPK3']",0.9999288470839088,0,0,12
132,Copper homeostasis WP3286,0.2748219592229292,1.4357779244349118,1.8544964421539345,"['PRNP', 'JUN', 'SCO2', 'COX17', 'ATOX1', 'SOD1']",0.9999288470839088,0,0,6
133,IL-3 signaling pathway WP286,0.2748219592229292,1.4357779244349118,1.8544964421539345,"['JUN', 'YWHAB', 'BAD', 'FOS', 'HRAS', 'MAPK3']",0.9999288470839088,0,0,6
134,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.2832617776049453,1.2854161115552003,1.621403058978194,"['CDKN1A', 'JUN', 'GADD45B', 'DCC', 'BAD', 'GADD45A', 'CYCS', 'BAX', 'FOS', 'MAPK3']",0.9999288470839088,0,0,10
135,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.29134432760510065,1.7343283582089553,2.138859502433989,"['JUN', 'PRKCQ', 'MAPK3']",0.9999288470839088,0,0,3
136,Modulators of TCR signaling and T cell activation WP5072,0.294867882738235,1.349358334995678,1.6478740162217358,"['FIBP', 'CDKN1B', 'NDUFB10', 'ELOB', 'PRKCQ', 'RNF7', 'MEF2D']",0.9999288470839088,0,0,7
137,Glycogen Synthesis and Degradation WP500,0.29771994197032386,1.387799043062201,1.6814601328157548,"['GYS2', 'GSK3A', 'PHKA1', 'CALM3', 'CALM1', 'CALM2']",0.9999288470839088,0,0,6
138,7-oxo-C and 7beta-HC pathways WP5064,0.29824405920272995,1.5417496349395992,1.8652752148861942,"['HSD11B1', 'HSD11B2', 'DBP', 'ACOT11']",0.9999288470839088,0,0,4
139,DNA Mismatch Repair WP531,0.29824405920272995,1.5417496349395992,1.8652752148861942,"['POLE4', 'POLD4', 'RPA3', 'POLE3']",0.9999288470839088,0,0,4
140,Physiological and pathological hypertrophy of the heart WP1528,0.29824405920272995,1.5417496349395992,1.8652752148861942,"['JUN', 'FOS', 'CALM1', 'CALM2']",0.9999288470839088,0,0,4
141,Synaptic Vesicle Pathway WP2267,0.31598161374348605,1.3127759716628657,1.5124114565393256,"['RAB3A', 'CLTCL1', 'PARK7', 'SYN3', 'SLC25A4', 'SLC18A2', 'AP2M1']",0.9999288470839088,0,0,7
142,Estrogen Receptor Pathway WP2881,0.3165664490173641,1.9817592908285033,2.2794633528746564,"['JUN', 'CYP1B1']",0.9999288470839088,0,0,2
143,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.3165664490173641,1.9817592908285033,2.2794633528746564,"['PRKCQ', 'MAFK']",0.9999288470839088,0,0,2
144,Genes targeted by miRNAs in adipocytes WP1992,0.3165664490173641,1.9817592908285033,2.2794633528746564,"['TMSB4X', 'KCNJ2']",0.9999288470839088,0,0,2
145,Matrix Metalloproteinases WP129,0.3165664490173641,1.9817592908285033,2.2794633528746564,"['TIMP2', 'TIMP3']",0.9999288470839088,0,0,2
146,Neuroinflammation WP4919,0.3165664490173641,1.9817592908285033,2.2794633528746564,"['JUN', 'FOS']",0.9999288470839088,0,0,2
147,Purine metabolism WP4792,0.3165664490173641,1.9817592908285033,2.2794633528746564,"['PRPS1', 'APRT']",0.9999288470839088,0,0,2
148,Leptin signaling pathway WP2034,0.31732333550224,1.2392942788626242,1.4225041577719486,"['GSK3A', 'BAD', 'CFL2', 'RPS6', 'LEPR', 'BAX', 'ELK1', 'HRAS', 'ACACB', 'MAPK3']",0.9999288470839088,0,0,10
149,G Protein Signaling Pathways WP35,0.32064775651560845,1.2070567357377733,1.3729209246508618,"['GNG10', 'GNG3', 'PRKCH', 'PRKD3', 'PRKAR1A', 'PRKCD', 'PRKCQ', 'PRKD1', 'AKAP5', 'CALM1', 'HRAS', 'CALM2']",0.9999288470839088,0,0,12
150,Pregnane X receptor pathway WP2876,0.3278575121925719,1.600780711825488,1.7851525176787082,"['HSP90AA1', 'PSMC5', 'CYP3A5']",0.9999288470839088,0,0,3
151,let-7 inhibition of ES cell reprogramming WP3299,0.33255546111018,3.4675014907573045,3.8175410243178294,['EGR1'],0.9999288470839088,0,0,1
152,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.33255546111018,3.4675014907573045,3.8175410243178294,['NRP1'],0.9999288470839088,0,0,1
153,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.33255546111018,3.4675014907573045,3.8175410243178294,['MAS1'],0.9999288470839088,0,0,1
154,22q11.2 copy number variation syndrome WP4657,0.33633247375661973,1.1897101697821986,1.2963737576280605,"['SLC7A4', 'ACTA2', 'RANBP1', 'CYP26B1', 'MRPL40', 'SERPIND1', 'THAP7', 'CLTCL1', 'HIST1H4C', 'RTN4', 'RAN', 'FGF10']",0.9999288470839088,0,0,12
155,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.3373496611965728,1.2781189958738859,1.3888492392451066,"['VAV3', 'BEX3', 'CDKN1A', 'CDKN1B', 'HSPA5', 'NRG1', 'RNF7']",0.9999288470839088,0,0,7
156,TGF-beta Receptor Signaling WP560,0.34444976881150935,1.3008373205741626,1.386441532698131,"['JUN', 'FOS', 'ZNF423', 'HRAS', 'LTBP1', 'MAPK3']",0.9999288470839088,0,0,6
157,IL-2 signaling pathway WP49,0.35162669359317994,1.3340843257161248,1.3943651870649378,"['JUN', 'RPS6', 'FOS', 'HRAS', 'MAPK3']",0.9999288470839088,0,0,5
158,Osteoblast differentiation WP4787,0.35216575722373167,1.1728522394873442,1.2240511254232291,"['FZD1', 'PRKCH', 'JAG1', 'HEY1', 'PRKCD', 'PRKCQ', 'PRKD1', 'FGF1', 'WNT2', 'FGF10', 'DLL3', 'MAPK3']",0.9999288470839088,0,0,12
159,Apoptosis WP254,0.360948533860596,1.20085726137254,1.223697441949897,"['JUN', 'CRADD', 'CDKN2A', 'BAD', 'CYCS', 'BAX', 'FADD', 'NFKBIE', 'BCL2L2']",0.9999288470839088,0,0,9
160,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.3643291064606881,1.4863113006396589,1.500725073803553,"['EIF5', 'EIF1AX', 'EIF1']",0.9999288470839088,0,0,3
161,Triacylglyceride synthesis WP325,0.3643291064606881,1.4863113006396589,1.500725073803553,"['DGAT2', 'LPL', 'AGPAT1']",0.9999288470839088,0,0,3
162,Cysteine and methionine catabolism WP4504,0.3652569966490745,1.733890214797136,1.7462945915405879,"['AHCY', 'GOT1']",0.9999288470839088,0,0,2
163,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.3652569966490745,1.733890214797136,1.7462945915405879,"['GABBR1', 'GRM4']",0.9999288470839088,0,0,2
164,Nanoparticle triggered regulated necrosis WP2513,0.3652569966490745,1.733890214797136,1.7462945915405879,"['FADD', 'FTL']",0.9999288470839088,0,0,2
165,Hepatitis B infection WP4666,0.3766372008525631,1.1214916918888038,1.095106229933254,"['JUN', 'EGR2', 'CDKN1A', 'EGR3', 'ATP6AP1', 'SLC10A1', 'YWHAB', 'BAD', 'FOS', 'ELK1', 'CREB3', 'CYCS', 'BAX', 'FADD', 'HRAS', 'MAPK3']",0.9999288470839088,0,0,16
166,G13 Signaling Pathway WP524,0.3780051291314438,1.2845631046467867,1.249684023347697,"['CFL2', 'CFL1', 'ARHGDIG', 'CALM1', 'CALM2']",0.9999288470839088,0,0,5
167,Signaling of Hepatocyte Growth Factor Receptor WP313,0.3780051291314438,1.2845631046467867,1.249684023347697,"['JUN', 'FOS', 'ELK1', 'HRAS', 'MAPK3']",0.9999288470839088,0,0,5
168,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.39178888183997623,1.22410638896707,1.147027042713493,"['JUN', 'PRKCQ', 'FOS', 'CALM1', 'CALM2', 'MAPK3']",0.9999288470839088,0,0,6
169,Globo Sphingolipid Metabolism WP1424,0.4004551816874334,1.3871044776119403,1.2694134130126913,"['ST6GALNAC3', 'FUT1', 'ABO']",0.9999288470839088,0,0,3
170,Heart Development WP1591,0.4004551816874334,1.3871044776119403,1.2694134130126913,"['HEY1', 'BHLHE40', 'FGF10']",0.9999288470839088,0,0,3
171,Nucleotide metabolism WP404,0.4004551816874334,1.3871044776119403,1.2694134130126913,"['PRPS1', 'NME2', 'OAZ1']",0.9999288470839088,0,0,3
172,"Relationship between inflammation, COX-2 and EGFR WP4483",0.4004551816874334,1.3871044776119403,1.2694134130126913,"['PTGES2', 'HRAS', 'MAPK3']",0.9999288470839088,0,0,3
173,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.4004551816874334,1.3871044776119403,1.2694134130126913,"['ELK1', 'HRAS', 'MAPK3']",0.9999288470839088,0,0,3
174,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.4004551816874334,1.3871044776119403,1.2694134130126913,"['EGR1', 'ELK1', 'MAPK3']",0.9999288470839088,0,0,3
175,Amyotrophic lateral sclerosis (ALS) WP2447,0.4043534817149912,1.2385791136538298,1.1214910637169366,"['BAD', 'NEFL', 'BAX', 'NEFM', 'SOD1']",0.9999288470839088,0,0,5
176,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.4043534817149912,1.2385791136538298,1.1214910637169366,"['JUN', 'RPS6KA2', 'DDIT3', 'FOS', 'MAPK3']",0.9999288470839088,0,0,5
177,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.4125401148230707,1.5411031556616281,1.3645263761193887,"['CDKN1A', 'ROS1']",0.9999288470839088,0,0,2
178,GDNF/RET signaling axis WP4830,0.4125401148230707,1.5411031556616281,1.3645263761193887,"['GFRA1', 'SPRY1']",0.9999288470839088,0,0,2
179,GPR40 Pathway WP3958,0.4125401148230707,1.5411031556616281,1.3645263761193887,"['PLCH1', 'PLCB2']",0.9999288470839088,0,0,2
180,Hypertrophy Model WP516,0.4125401148230707,1.5411031556616281,1.3645263761193887,"['NR4A3', 'WDR1']",0.9999288470839088,0,0,2
181,RalA downstream regulated genes WP2290,0.4125401148230707,1.5411031556616281,1.3645263761193887,"['EXOC8', 'HRAS']",0.9999288470839088,0,0,2
182,RAS and bradykinin pathways in COVID-19 WP4969,0.4125401148230707,1.5411031556616281,1.3645263761193887,"['F12', 'KLKB1']",0.9999288470839088,0,0,2
183,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.4125401148230707,1.5411031556616281,1.3645263761193887,"['ANAPC11', 'MAD2L1']",0.9999288470839088,0,0,2
184,Cytosolic DNA-sensing pathway WP4655,0.4154614404185609,1.1890293916609707,1.0444023626337549,"['POLR2E', 'POLR3H', 'FADD', 'POLR3K', 'POLR2K', 'POLR2L']",0.9999288470839088,0,0,6
185,Pathogenic Escherichia coli infection WP2272,0.4154614404185609,1.1890293916609707,1.0444023626337549,"['TUBB8', 'TUBA1A', 'TUBB2A', 'ARPC5L', 'TUBA4A', 'ACTG1']",0.9999288470839088,0,0,6
186,Cells and molecules involved in local acute inflammatory response  WP4493,0.4167194546622204,2.3114688928642417,2.023325928874272,['SELP'],0.9999288470839088,0,0,1
187,Composition of Lipid Particles WP3601,0.4167194546622204,2.3114688928642417,2.023325928874272,['LPL'],0.9999288470839088,0,0,1
188,Fatty Acid Omega Oxidation WP206,0.4167194546622204,2.3114688928642417,2.023325928874272,['ALDH1A1'],0.9999288470839088,0,0,1
189,Irinotecan pathway WP229,0.4167194546622204,2.3114688928642417,2.023325928874272,['CYP3A5'],0.9999288470839088,0,0,1
190,Platelet-mediated interactions with vascular and circulating cells WP4462,0.4167194546622204,2.3114688928642417,2.023325928874272,['SELP'],0.9999288470839088,0,0,1
191,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.4167194546622204,2.3114688928642417,2.023325928874272,['ATP4A'],0.9999288470839088,0,0,1
192,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.4167194546622204,2.3114688928642417,2.023325928874272,['DLL3'],0.9999288470839088,0,0,1
193,Sulindac Metabolic Pathway WP2542,0.4167194546622204,2.3114688928642417,2.023325928874272,['CYP1B1'],0.9999288470839088,0,0,1
194,Vitamin B6-dependent and responsive disorders WP4228,0.4167194546622204,2.3114688928642417,2.023325928874272,['AASS'],0.9999288470839088,0,0,1
195,Folate Metabolism WP176,0.4187688685076404,1.2609970674486803,1.0976174170855302,"['AHCY', 'GPX4', 'RFK', 'SOD1']",0.9999288470839088,0,0,4
196,DNA Replication WP466,0.4305580599353888,1.195766432384525,1.0076402039706343,"['POLD4', 'RPA3', 'UBC', 'MCM4', 'UBA52']",0.9999288470839088,0,0,5
197,NO/cGMP/PKG mediated Neuroprotection WP4008,0.4305580599353888,1.195766432384525,1.0076402039706343,"['BAD', 'NEFL', 'CYCS', 'CALM1', 'CALM2']",0.9999288470839088,0,0,5
198,Gastric Cancer Network 1 WP2361,0.43597550889858544,1.3002985074626865,1.0794677840046225,"['MCM4', 'GATD3B', 'GATD3A']",0.9999288470839088,0,0,3
199,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.43597550889858544,1.3002985074626865,1.0794677840046225,"['BAD', 'BAX', 'FADD']",0.9999288470839088,0,0,3
200,IL-7 signaling pathway WP205,0.43597550889858544,1.3002985074626865,1.0794677840046225,"['CDKN1B', 'BAD', 'MAPK3']",0.9999288470839088,0,0,3
201,Striated Muscle Contraction Pathway WP383,0.43597550889858544,1.3002985074626865,1.0794677840046225,"['ACTA2', 'MYOM1', 'ACTG1']",0.9999288470839088,0,0,3
202,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.43902462685179156,1.1559011164274322,0.951537533033338,"['JUN', 'FOS', 'ZNF423', 'HRAS', 'LTBP1', 'MAPK3']",0.9999288470839088,0,0,6
203,GABA receptor Signaling WP4159,0.4484061505562671,1.2060672172874136,0.9673332926932412,"['GABBR1', 'GABRD', 'GABRG3', 'AP2M1']",0.9999288470839088,0,0,4
204,Metapathway biotransformation Phase I and II WP702,0.4487014403287374,1.0808998924245024,0.8662305320712582,"['CYP39A1', 'CYP26B1', 'GPX4', 'GSTP1', 'CYP1B1', 'GLYAT', 'NAT8L', 'CYP2C18', 'SULT4A1', 'CYP3A5', 'CHST2', 'HS3ST2']",0.9999288470839088,0,0,12
205,Cancer immunotherapy by PD-1 blockade WP4585,0.45799682864505964,1.386873508353222,1.0829998412525845,"['JUN', 'PDCD1LG2']",0.9999288470839088,0,0,2
206,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.45799682864505964,1.386873508353222,1.0829998412525845,"['RYR1', 'CCK']",0.9999288470839088,0,0,2
207,Ganglio Sphingolipid Metabolism WP1423,0.45799682864505964,1.386873508353222,1.0829998412525845,"['B3GALT1', 'FUT1']",0.9999288470839088,0,0,2
208,Major receptors targeted by epinephrine and norepinephrine WP4589,0.45799682864505964,1.386873508353222,1.0829998412525845,"['ADCY10', 'ADRA1D']",0.9999288470839088,0,0,2
209,miRNAs involved in DNA damage response WP1545,0.45799682864505964,1.386873508353222,1.0829998412525845,"['CDKN1A', 'CDKN1B']",0.9999288470839088,0,0,2
210,NOTCH1 regulation of endothelial cell calcification WP3413,0.45799682864505964,1.386873508353222,1.0829998412525845,"['JAG1', 'DLL3']",0.9999288470839088,0,0,2
211,Overview of nanoparticle effects WP3287,0.45799682864505964,1.386873508353222,1.0829998412525845,"['LAMA3', 'BAX']",0.9999288470839088,0,0,2
212,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.45799682864505964,1.386873508353222,1.0829998412525845,"['FZD1', 'DKK3']",0.9999288470839088,0,0,2
213,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.47067160193870516,1.2237050043898157,0.9221775615528788,"['FSHR', 'RPS6', 'MAPK3']",0.9999288470839088,0,0,3
214,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.47067160193870516,1.2237050043898157,0.9221775615528788,"['GSK3A', 'CALM1', 'CALM2']",0.9999288470839088,0,0,3
215,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.4737682755257941,1.0760728084130493,0.8038661455700616,"['CREB3', 'BAD', 'RPS6', 'DIO1', 'ZNF516', 'ITPR2', 'PRKCQ', 'HRAS', 'TSHR']",0.9999288470839088,0,0,9
216,Prion disease pathway WP3995,0.4775461491123038,1.155714854639586,0.8541824653295749,"['PRNP', 'HSPA5', 'ELK1', 'MAPK3']",0.9999288470839088,0,0,4
217,IL-4 signaling pathway WP395,0.4855202891872491,1.0948753462603877,0.7910848844146369,"['CEBPA', 'CEBPB', 'BAD', 'FOS', 'ELK1', 'MAPK3']",0.9999288470839088,0,0,6
218,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.49027597244087767,1.7334525939177101,1.2355821921271488,['CYP2C18'],0.9999288470839088,0,0,1
219,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.49027597244087767,1.7334525939177101,1.2355821921271488,['CDKN1A'],0.9999288470839088,0,0,1
220,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.49027597244087767,1.7334525939177101,1.2355821921271488,['HEY1'],0.9999288470839088,0,0,1
221,PTF1A related regulatory pathway WP4147,0.49027597244087767,1.7334525939177101,1.2355821921271488,['FGF10'],0.9999288470839088,0,0,1
222,SARS-CoV-2 and COVID-19 Pathway WP4846,0.49027597244087767,1.7334525939177101,1.2355821921271488,['NRP1'],0.9999288470839088,0,0,1
223,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.49027597244087767,1.7334525939177101,1.2355821921271488,['MAPK3'],0.9999288470839088,0,0,1
224,The alternative pathway of fetal androgen synthesis WP4524,0.49027597244087767,1.7334525939177101,1.2355821921271488,['STAR'],0.9999288470839088,0,0,1
225,Fatty acid transporters WP5061,0.5013360516632581,1.2606856151008896,0.8704764901857676,"['FABP7', 'ACSL5']",0.9999288470839088,0,0,2
226,Nicotine Activity on Dopaminergic Neurons WP1602,0.5013360516632581,1.2606856151008896,0.8704764901857676,"['CHRNB2', 'SLC18A2']",0.9999288470839088,0,0,2
227,Tryptophan catabolism leading to NAD+ production WP4210,0.5013360516632581,1.2606856151008896,0.8704764901857676,"['TDO2', 'KMO']",0.9999288470839088,0,0,2
228,Cardiac Progenitor Differentiation WP2406,0.504364027994467,1.1556218905472637,0.7909734852439717,"['MESP1', 'NRG1', 'THY1']",0.9999288470839088,0,0,3
229,Differentiation Pathway WP2848,0.504364027994467,1.1556218905472637,0.7909734852439717,"['FGF1', 'WNT2', 'FGF10']",0.9999288470839088,0,0,3
230,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.504364027994467,1.1556218905472637,0.7909734852439717,"['FZD1', 'ADAMTS2', 'PLOD2']",0.9999288470839088,0,0,3
231,Melatonin metabolism and effects WP3298,0.5060695601527762,1.1093906810035843,0.7555850791367393,"['PER2', 'CYP1B1', 'CALM1', 'CALM2']",0.9999288470839088,0,0,4
232,Common Pathways Underlying Drug Addiction WP2636,0.5073079224533666,1.0833831440526,0.7352240141703457,"['PPP1R1A', 'CALM1', 'CALM2', 'ACTG1', 'MAPK3']",0.9999288470839088,0,0,5
233,Retinoblastoma gene in cancer WP2446,0.5288327879720653,1.0228859923975286,0.6516632642983496,"['CDKN1A', 'CDKN1B', 'CCNE2', 'TFDP2', 'H2AFZ', 'SUV39H1', 'RPA3', 'STMN1', 'MCM4']",0.9999288470839088,0,0,9
234,Acute viral myocarditis WP4298,0.5298642375887808,1.0325706354966449,0.6558211937544521,"['ENDOG', 'LAMA2', 'CYCS', 'BAX', 'SGCG', 'EIF4G2', 'MAPK3']",0.9999288470839088,0,0,7
235,Bladder cancer WP2828,0.5338740737488764,1.0666299053395827,0.6694118991973139,"['CDKN1A', 'CDKN2A', 'DAPK2', 'HRAS']",0.9999288470839088,0,0,4
236,MAPK Cascade WP422,0.5338740737488764,1.0666299053395827,0.6694118991973139,"['JUN', 'ELK1', 'HRAS', 'MAPK3']",0.9999288470839088,0,0,4
237,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.5338740737488764,1.0666299053395827,0.6694118991973139,"['LDHA', 'PKM', 'PGK1', 'BAX']",0.9999288470839088,0,0,4
238,Estrogen signaling pathway WP712,0.5369092680024896,1.0947054202670856,0.6808259379616004,"['JUN', 'FOS', 'ELK1']",0.9999288470839088,0,0,3
239,Unfolded protein response WP4925,0.5369092680024896,1.0947054202670856,0.6808259379616004,"['XBP1', 'HSPA5', 'DDIT3']",0.9999288470839088,0,0,3
240,Eicosanoid Synthesis WP167,0.5423690294523156,1.1555290373906126,0.7069626524037618,"['PTGES2', 'PTGES']",0.9999288470839088,0,0,2
241,DNA damage response WP707,0.5501945076520062,1.0109714741671654,0.6040386868297907,"['CDKN1A', 'CDKN1B', 'CCNE2', 'GADD45B', 'GADD45A', 'CYCS', 'BAX']",0.9999288470839088,0,0,7
242,Kit receptor signaling pathway WP304,0.5527041675614438,1.0144999416501341,0.6015298647128798,"['BAD', 'RPS6', 'MITF', 'FOS', 'HRAS', 'MAPK3']",0.9999288470839088,0,0,6
243,Benzo(a)pyrene metabolism WP696,0.554561212052106,1.3866428145497913,0.8175342177422384,['CYP1B1'],0.9999288470839088,0,0,1
244,Drug Induction of Bile Acid Pathway WP2289,0.554561212052106,1.3866428145497913,0.8175342177422384,['SLC10A1'],0.9999288470839088,0,0,1
245,EDA signaling in hair follicle development WP3930,0.554561212052106,1.3866428145497913,0.8175342177422384,['SOSTDC1'],0.9999288470839088,0,0,1
246,Insulin signaling in adipocytes (diabetic condition) WP3635,0.554561212052106,1.3866428145497913,0.8175342177422384,['RPS6'],0.9999288470839088,0,0,1
247,Insulin signaling in adipocytes (normal condition) WP3634,0.554561212052106,1.3866428145497913,0.8175342177422384,['RPS6'],0.9999288470839088,0,0,1
248,LDLRAD4 and what we know about it WP4904,0.554561212052106,1.3866428145497913,0.8175342177422384,['PMEPA1'],0.9999288470839088,0,0,1
249,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.554561212052106,1.3866428145497913,0.8175342177422384,['BAX'],0.9999288470839088,0,0,1
250,miRNA Biogenesis WP2338,0.554561212052106,1.3866428145497913,0.8175342177422384,['RAN'],0.9999288470839088,0,0,1
251,Nephrogenesis WP5052,0.554561212052106,1.3866428145497913,0.8175342177422384,['JAG1'],0.9999288470839088,0,0,1
252,Vitamin B12 Disorders WP4271,0.554561212052106,1.3866428145497913,0.8175342177422384,['CUBN'],0.9999288470839088,0,0,1
253,Pathways Regulating Hippo Signaling WP4540,0.5643920036077522,0.9902422323033467,0.5664247231714383,"['PRKCH', 'PRKD3', 'PRKAR1A', 'FLT3', 'PRKCD', 'PRKCQ', 'PLCB2', 'CDH18', 'CDH7']",0.9999288470839088,0,0,9
254,T-cell receptor (TCR) signaling pathway WP69,0.5669543022948487,0.9902480752780154,0.5619425852701637,"['VAV3', 'JUN', 'PRKCD', 'PRKCQ', 'FOS', 'HRAS', 'SKAP1', 'MAPK3']",0.9999288470839088,0,0,8
255,16p11.2 distal deletion syndrome WP4950,0.5681963417696376,1.0398805970149254,0.5878322806724533,"['CD81', 'TUFM', 'VAV2']",0.9999288470839088,0,0,3
256,Oxidative Stress WP408,0.5681963417696376,1.0398805970149254,0.5878322806724533,"['NOX4', 'FOS', 'SOD1']",0.9999288470839088,0,0,3
257,Notch Signaling Pathway Netpath WP61,0.5741960850035642,0.9902597402597403,0.5493805860249306,"['PSENEN', 'CDKN1A', 'JAG1', 'HEY1', 'SKP1', 'DLL3']",0.9999288470839088,0,0,6
258,ERK Pathway in Huntington's Disease WP3853,0.5809881880503582,1.066550394712686,0.5791633710019085,"['ELK1', 'HRAS']",0.9999288470839088,0,0,2
259,B Cell Receptor Signaling Pathway WP23,0.5817393702295046,0.9746854403834632,0.5280190230545196,"['JUN', 'GSK3A', 'CD81', 'PRKCD', 'ELK1', 'ILF2', 'HRAS', 'MEF2D', 'VAV2']",0.9999288470839088,0,0,9
260,Vitamin D-sensitive calcium signaling in depression WP4698,0.5869977299567092,0.9902713773681515,0.5275515551320699,"['CALB1', 'GPX4', 'KCNQ3', 'ITPR2']",0.9999288470839088,0,0,4
261,miRNA regulation of DNA damage response WP1530,0.5896574567847732,0.9703650508677438,0.5125599124275032,"['CDKN1A', 'CDKN1B', 'CCNE2', 'GADD45B', 'GADD45A', 'CYCS', 'BAX']",0.9999288470839088,0,0,7
262,Cell Differentiation - Index WP2029,0.6107431418274445,1.1554362949711787,0.5697211394979264,['MEF2D'],0.9999288470839088,0,0,1
263,"Cerebral organic acidurias, including diseases WP4519",0.6107431418274445,1.1554362949711787,0.5697211394979264,['MDH2'],0.9999288470839088,0,0,1
264,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.6107431418274445,1.1554362949711787,0.5697211394979264,['DHCR24'],0.9999288470839088,0,0,1
265,Estrogen metabolism WP697,0.6107431418274445,1.1554362949711787,0.5697211394979264,['CYP1B1'],0.9999288470839088,0,0,1
266,Methylation Pathways WP704,0.6107431418274445,1.1554362949711787,0.5697211394979264,['MAT2B'],0.9999288470839088,0,0,1
267,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.6107431418274445,1.1554362949711787,0.5697211394979264,['JUN'],0.9999288470839088,0,0,1
268,Sulfation Biotransformation Reaction WP692,0.6107431418274445,1.1554362949711787,0.5697211394979264,['SULT4A1'],0.9999288470839088,0,0,1
269,p38 MAPK Signaling Pathway WP400,0.6121900221991138,0.956041692415441,0.4691416576267239,"['DDIT3', 'ELK1', 'HRAS', 'MEF2D']",0.9999288470839088,0,0,4
270,Type 2 papillary renal cell carcinoma WP4241,0.6121900221991138,0.956041692415441,0.4691416576267239,"['CDKN1A', 'COL21A1', 'ELOB', 'ELOC']",0.9999288470839088,0,0,4
271,Microglia Pathogen Phagocytosis Pathway WP3937,0.6171496851470607,0.9902829867030344,0.4779538278797332,"['VAV3', 'VAV2']",0.9999288470839088,0,0,2
272,One-carbon metabolism WP241,0.6171496851470607,0.9902829867030344,0.4779538278797332,"['AHCY', 'MAT2B']",0.9999288470839088,0,0,2
273,Proteoglycan biosynthesis WP4784,0.6171496851470607,0.9902829867030344,0.4779538278797332,"['XYLT1', 'B3GALT6']",0.9999288470839088,0,0,2
274,Transcription factor regulation in adipogenesis WP3599,0.6171496851470607,0.9902829867030344,0.4779538278797332,"['CEBPA', 'CEBPB']",0.9999288470839088,0,0,2
275,Urea cycle and metabolism of amino groups WP497,0.6171496851470607,0.9902829867030344,0.4779538278797332,"['ODC1', 'CKB']",0.9999288470839088,0,0,2
276,Glycosylation and related congenital defects WP4521,0.6266941031222929,0.9451831750339214,0.44168100808474225,"['DPM3', 'DOLK', 'MGAT2']",0.9999288470839088,0,0,3
277,IL17 signaling pathway WP2112,0.6266941031222929,0.9451831750339214,0.44168100808474225,"['CEBPB', 'IL17RE', 'MAPK3']",0.9999288470839088,0,0,3
278,Glioblastoma signaling pathways WP2261,0.6317675142759059,0.9308013557139407,0.42745545263023277,"['CDKN1A', 'CDKN1B', 'PRKCH', 'CDKN2C', 'CDKN2A', 'PRKCD', 'PRKCQ', 'HRAS', 'MAPK3']",0.9999288470839088,0,0,9
279,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.6353807014493729,0.9240031897926635,0.41906402589180913,"['FZD1', 'JUN', 'FRAT2', 'SFRP2', 'ROR1', 'WNT2']",0.9999288470839088,0,0,6
280,ATM Signaling Pathway WP2516,0.6364075984992575,0.9240939864595779,0.4176128975113477,"['CDKN1A', 'JUN', 'CRADD', 'GADD45A']",0.9999288470839088,0,0,4
281,Phosphoinositides metabolism WP4971,0.6364075984992575,0.9240939864595779,0.4176128975113477,"['PIP4P1', 'PLCH1', 'PIP4K2C', 'PLCB2']",0.9999288470839088,0,0,4
282,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6457358896953909,0.9118507565986095,0.3988113310343177,"['ADCY10', 'CFL1', 'BANF1', 'HRAS', 'MAPK3']",0.9999288470839088,0,0,5
283,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6457358896953909,0.9118507565986095,0.3988113310343177,"['EIF4A2', 'RPS6KA2', 'PRKCD', 'RPS6', 'MAPK3']",0.9999288470839088,0,0,5
284,Constitutive Androstane Receptor Pathway WP2875,0.6508590661704361,0.9241845664280032,0.39690228944215206,"['HSP90AA1', 'CYP3A5']",0.9999288470839088,0,0,2
285,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.6508590661704361,0.9241845664280032,0.39690228944215206,"['LTBP1', 'MAPK3']",0.9999288470839088,0,0,2
286,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.6508590661704361,0.9241845664280032,0.39690228944215206,"['HRAS', 'MAPK3']",0.9999288470839088,0,0,2
287,Purine metabolism and related disorders WP4224,0.6508590661704361,0.9241845664280032,0.39690228944215206,"['PRPS1', 'APRT']",0.9999288470839088,0,0,2
288,Purinergic signaling WP4900,0.6508590661704361,0.9241845664280032,0.39690228944215206,"['P2RY12', 'P2RY14']",0.9999288470839088,0,0,2
289,Vitamin B12 metabolism WP1533,0.6508590661704361,0.9241845664280032,0.39690228944215206,"['CUBN', 'SOD1']",0.9999288470839088,0,0,2
290,Endothelin Pathways WP2197,0.6538147628045858,0.9040103828682674,0.3841422212759575,"['ADCY10', 'CALM1', 'CALM2']",0.9999288470839088,0,0,3
291,Nuclear receptors WP170,0.6538147628045858,0.9040103828682674,0.3841422212759575,"['NR4A1', 'RARB', 'ROR1']",0.9999288470839088,0,0,3
292,Oxysterols derived from cholesterol WP4545,0.6538147628045858,0.9040103828682674,0.3841422212759575,"['CYP39A1', 'DBP', 'ACOT11']",0.9999288470839088,0,0,3
293,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.6538147628045858,0.9040103828682674,0.3841422212759575,"['CDKN1B', 'BAD', 'HRAS']",0.9999288470839088,0,0,3
294,3q29 copy number variation syndrome WP4906,0.6545775697146649,0.9038381526939879,0.3830151403036166,"['JUN', 'NCBP2', 'DYNLT3', 'MAD2L1BP', 'DYNLL1', 'DYNLL2']",0.9999288470839088,0,0,6
295,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6596196477085896,0.8942074228234478,0.3720724668371929,"['JUN', 'CYCS', 'FADD', 'ACTG1']",0.9999288470839088,0,0,4
296,Hepatitis C and Hepatocellular Carcinoma WP3646,0.6596196477085896,0.8942074228234478,0.3720724668371929,"['CDKN1A', 'JUN', 'VAV2', 'MAPK3']",0.9999288470839088,0,0,4
297,Biomarkers for urea cycle disorders WP4583,0.659842669863742,0.9902887809864555,0.41171637466637895,['GOT1'],0.9999288470839088,0,0,1
298,Canonical NF-KB pathway WP4562,0.659842669863742,0.9902887809864555,0.41171637466637895,['NFKBIE'],0.9999288470839088,0,0,1
299,"Degradation pathway of sphingolipids, including diseases WP4153",0.659842669863742,0.9902887809864555,0.41171637466637895,['NEU1'],0.9999288470839088,0,0,1
300,IL1 and megakaryocytes in obesity WP2865,0.659842669863742,0.9902887809864555,0.41171637466637895,['TIMP2'],0.9999288470839088,0,0,1
301,Iron metabolism in placenta WP2007,0.659842669863742,0.9902887809864555,0.41171637466637895,['FTH1'],0.9999288470839088,0,0,1
302,Leptin and adiponectin WP3934,0.659842669863742,0.9902887809864555,0.41171637466637895,['LEPR'],0.9999288470839088,0,0,1
303,Mitochondrial CII Assembly WP4920,0.659842669863742,0.9902887809864555,0.41171637466637895,['SDHAF1'],0.9999288470839088,0,0,1
304,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.6662763342941669,0.8883933360920808,0.36073280541291797,"['XBP1', 'MAP1LC3A', 'HSPA5', 'PPP1R1A', 'DDIT3']",0.9999288470839088,0,0,5
305,Nucleotide Excision Repair WP4753,0.6662763342941669,0.8883933360920808,0.36073280541291797,"['POLE4', 'POLD4', 'CETN2', 'RPA3', 'POLE3']",0.9999288470839088,0,0,5
306,Pancreatic adenocarcinoma pathway WP4263,0.6783863288636145,0.8906787640160918,0.34561751506199656,"['CDKN1A', 'GADD45B', 'CDKN2A', 'BAD', 'GADD45A', 'PRKCD', 'BAX', 'DUSP6', 'MAPK3']",0.9999288470839088,0,0,9
307,Intraflagellar transport proteins binding to dynein WP4532,0.6794908153766733,0.866268656716418,0.3347362249440797,"['DYNLT3', 'DYNLL1', 'DYNLL2']",0.9999288470839088,0,0,3
308,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.6794908153766733,0.866268656716418,0.3347362249440797,"['NDUFA13', 'HSP90AA1', 'AAMP']",0.9999288470839088,0,0,3
309,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.6794908153766733,0.866268656716418,0.3347362249440797,"['ACTA2', 'BAX', 'PRKCQ']",0.9999288470839088,0,0,3
310,Apoptosis Modulation by HSP70 WP384,0.6821595210646298,0.8663484486873508,0.3313711313330799,"['CYCS', 'FADD']",0.9999288470839088,0,0,2
311,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.6821595210646298,0.8663484486873508,0.3313711313330799,"['B3GALT1', 'ST6GALNAC3']",0.9999288470839088,0,0,2
312,NAD+ biosynthetic pathways WP3645,0.6821595210646298,0.8663484486873508,0.3313711313330799,"['TDO2', 'ACMSD']",0.9999288470839088,0,0,2
313,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.6821595210646298,0.8663484486873508,0.3313711313330799,"['MDH2', 'IDH3B']",0.9999288470839088,0,0,2
314,TYROBP causal network in microglia WP3945,0.6821595210646298,0.8663484486873508,0.3313711313330799,"['RBM47', 'SAMSN1']",0.9999288470839088,0,0,2
315,Corticotropin-releasing hormone signaling pathway WP2355,0.6866246383362292,0.879688242562494,0.33073420169194834,"['NR4A1', 'HSP90AA1', 'STAR', 'PRKCD', 'PRKCQ', 'FOS', 'ELK1', 'MAPK3']",0.9999288470839088,0,0,8
316,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6910473637051693,0.8660287081339713,0.3200382363974711,"['BAD', 'STMN1', 'BAX', 'HRAS', 'ANGPTL1', 'MAPK3']",0.9999288470839088,0,0,6
317,EGF/EGFR signaling pathway WP437,0.6968309742139784,0.8985527894076502,0.3245684116958799,"['VAV3', 'NDUFA13', 'JUN', 'CAV2', 'PRKCD', 'NEDD8', 'FOS', 'ELK1', 'EPN1', 'VAV2', 'RPS6KA2', 'CFL1', 'STMN1', 'HRAS', 'MEF2D', 'AP2M1', 'ARF6']",0.9999288470839088,0,0,17
318,Biotin Metabolism (including IEMs) WP5031,0.7027521508023287,0.8664281454979129,0.30563340224628677,['ACACB'],0.9999288470839088,0,0,1
319,Glutathione metabolism WP100,0.7027521508023287,0.8664281454979129,0.30563340224628677,['GPX4'],0.9999288470839088,0,0,1
320,miR-509-3p alteration of YAP1/ECM axis WP3967,0.7027521508023287,0.8664281454979129,0.30563340224628677,['SPARC'],0.9999288470839088,0,0,1
321,Serotonin and anxiety-related events WP3944,0.7027521508023287,0.8664281454979129,0.30563340224628677,['FOS'],0.9999288470839088,0,0,1
322,Thiamine metabolic pathways WP4297,0.7027521508023287,0.8664281454979129,0.30563340224628677,['SLC19A3'],0.9999288470839088,0,0,1
323,Integrated Cancer Pathway WP1971,0.7029576338081663,0.8398682162123022,0.2960188208897947,"['CDKN1A', 'CDKN1B', 'BAD', 'BAX']",0.9999288470839088,0,0,4
324,MET in type 1 papillary renal cell carcinoma WP4205,0.7082946360968411,0.84828141783029,0.2925681206980202,"['CDKN1A', 'JUN', 'BAD', 'RPL11', 'HRAS', 'MAPK3']",0.9999288470839088,0,0,6
325,Angiogenesis WP1539,0.7111223142848109,0.8153165800926576,0.2779502541778002,"['TIMP2', 'TIMP3']",0.9999288470839088,0,0,2
326,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.7111223142848109,0.8153165800926576,0.2779502541778002,"['H3F3B', 'SUV39H1']",0.9999288470839088,0,0,2
327,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.7111223142848109,0.8153165800926576,0.2779502541778002,"['FZD1', 'FGF1']",0.9999288470839088,0,0,2
328,Trans-sulfuration and one-carbon metabolism WP2525,0.7111223142848109,0.8153165800926576,0.2779502541778002,"['AHCY', 'MAT2B']",0.9999288470839088,0,0,2
329,Ebola Virus Pathway on Host WP4217,0.7128190442830741,0.8657074340527577,0.293065934068367,"['VPS18', 'CAV2', 'CLTCL1', 'FLNB', 'ACTG1', 'CTSB', 'RHOB', 'VAV2', 'HLA-DQB1', 'MAPK3']",0.9999288470839088,0,0,10
330,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.7166931477014133,0.8524735145094426,0.2839653186174808,"['SHC4', 'BAD', 'PDGFD', 'RPS6', 'BAX', 'NRG1', 'HRAS', 'MAPK3']",0.9999288470839088,0,0,8
331,ErbB signaling pathway WP673,0.7212467451926101,0.8538539195810796,0.27901723843264775,"['SHC4', 'CDKN1A', 'JUN', 'CDKN1B', 'BAD', 'NRG1', 'ELK1', 'HRAS', 'MAPK3']",0.9999288470839088,0,0,9
332,Cardiac Hypertrophic Response WP2795,0.7230851846819638,0.8247231947172174,0.2673985520767714,"['NRG1', 'PRKD1', 'CALM1', 'CALM2', 'MAPK3']",0.9999288470839088,0,0,5
333,miRNA regulation of prostate cancer signaling pathways WP3981,0.726530424026261,0.7994948335246843,0.2554185474351791,"['CDKN1A', 'CDKN1B', 'BAD']",0.9999288470839088,0,0,3
334,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.726530424026261,0.7994948335246843,0.2554185474351791,"['TNFSF4', 'RPS6', 'MAPK3']",0.9999288470839088,0,0,3
335,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.7378390274582444,0.7699549191195969,0.23408908465244166,"['CEBPA', 'CEBPB']",0.9999288470839088,0,0,2
336,PKC-gamma calcium signaling pathway in ataxia WP4760,0.7378390274582444,0.7699549191195969,0.23408908465244166,"['CA8', 'PLCB2']",0.9999288470839088,0,0,2
337,Signal Transduction of S1P Receptor WP26,0.7378390274582444,0.7699549191195969,0.23408908465244166,"['PLCB2', 'MAPK3']",0.9999288470839088,0,0,2
338,Urea cycle and associated pathways WP4595,0.7378390274582444,0.7699549191195969,0.23408908465244166,"['GOT1', 'MDH2']",0.9999288470839088,0,0,2
339,Alanine and aspartate metabolism WP106,0.740251564768869,0.770092095673491,0.2316169017599828,['GOT1'],0.9999288470839088,0,0,1
340,Development and heterogeneity of the ILC family WP3893,0.740251564768869,0.770092095673491,0.2316169017599828,['TOX'],0.9999288470839088,0,0,1
341,Dopamine metabolism WP2436,0.740251564768869,0.770092095673491,0.2316169017599828,['SOD1'],0.9999288470839088,0,0,1
342,ID signaling pathway WP53,0.740251564768869,0.770092095673491,0.2316169017599828,['ELK1'],0.9999288470839088,0,0,1
343,Osteoclast Signaling WP12,0.740251564768869,0.770092095673491,0.2316169017599828,['ATP6V1G1'],0.9999288470839088,0,0,1
344,Osteopontin Signaling WP1434,0.740251564768869,0.770092095673491,0.2316169017599828,['MAPK3'],0.9999288470839088,0,0,1
345,TCA cycle in senescence WP5050,0.740251564768869,0.770092095673491,0.2316169017599828,['GOT1'],0.9999288470839088,0,0,1
346,Endochondral Ossification with Skeletal Dysplasias WP4808,0.7421564115322846,0.7917392046424304,0.2360928786266382,"['ACAN', 'TIMP3', 'CALM1', 'CALM2']",0.9999288470839088,0,0,4
347,Endochondral Ossification WP474,0.7421564115322846,0.7917392046424304,0.2360928786266382,"['ACAN', 'TIMP3', 'CALM1', 'CALM2']",0.9999288470839088,0,0,4
348,Wnt signaling pathway and pluripotency WP399,0.7447831600086396,0.8268835463401555,0.2436512946113475,"['FZD1', 'JUN', 'PRKCH', 'PRKCD', 'PRKCQ', 'PPM1J', 'PRKD1', 'WNT2']",0.9999288470839088,0,0,8
349,Male infertility WP4673,0.7476352340149178,0.8309406830437388,0.24167085058557514,"['CYP26B1', 'SPATA17', 'MSH4', 'HMGA1', 'AHRR', 'HORMAD1', 'TEX15', 'CLU', 'ETV5']",0.9999288470839088,0,0,9
350,Fatty acid beta-oxidation WP143,0.7479366590661695,0.7698175787728027,0.22358349656804793,"['TPI1', 'LPL', 'ACSL5']",0.9999288470839088,0,0,3
351,Neural Crest Cell Migration during Development WP4564,0.7479366590661695,0.7698175787728027,0.22358349656804793,"['JUN', 'FOS', 'EPHB3']",0.9999288470839088,0,0,3
352,Ciliary landscape WP4352,0.7524194915807685,0.8748264756510633,0.2488542555556316,"['EXOC8', 'NDUFA5', 'SSNA1', 'DYNLT3', 'COPS7A', 'DYNLL1', 'COX6C', 'DYNLL2', 'LSM4', 'PSMD8', 'PSMD7', 'EXOSC4', 'ARHGDIA', 'CD2BP2', 'NEFL', 'ANKS6', 'MCM4', 'NEFM', 'TMED1', 'CALM1', 'DCAF11', 'CALM2']",0.9999288470839088,0,0,22
353,Histone Modifications WP2369,0.7602230603788954,0.7696800743395725,0.21100270346032277,"['SET', 'H3F3B', 'SUV39H1', 'HIST1H4C']",0.9999288470839088,0,0,4
354,Fatty Acid Biosynthesis WP357,0.7624153099067653,0.7293681698279111,0.19785121463778668,"['ACSL5', 'ACACB']",0.9999288470839088,0,0,2
355,Glycerolipids and Glycerophospholipids WP4722,0.7624153099067653,0.7293681698279111,0.19785121463778668,"['DGAT2', 'CDIPT']",0.9999288470839088,0,0,2
356,Type II interferon signaling (IFNG) WP619,0.7624153099067653,0.7293681698279111,0.19785121463778668,"['PRKCD', 'IFIT2']",0.9999288470839088,0,0,2
357,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.7705897471752731,0.7839893472961993,0.20430695897882362,"['FZD1', 'JUN', 'FRAT2', 'SFRP2', 'ROR1', 'WNT2']",0.9999288470839088,0,0,6
358,Focal Adhesion WP306,0.771741110716566,0.8451879001662671,0.21899336932587474,"['VAV3', 'SHC4', 'JUN', 'LAMA2', 'CAV2', 'BAD', 'LAMA4', 'LAMA3', 'ELK1', 'MYL12B', 'VAV2', 'ACTG1', 'PDGFD', 'FLNB', 'HRAS', 'MAPK3']",0.9999288470839088,0,0,16
359,ESC Pluripotency Pathways WP3931,0.7722499816993408,0.8092177445083377,0.20913987485156887,"['FZD1', 'FGF17', 'JUN', 'FOS', 'FGF1', 'ELK1', 'WNT2', 'HRAS', 'FGF10']",0.9999288470839088,0,0,9
360,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.7730226615281957,0.6930232558139535,0.17841669887760933,['EXPH5'],0.9999288470839088,0,0,1
361,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.7730226615281957,0.6930232558139535,0.17841669887760933,['JAG1'],0.9999288470839088,0,0,1
362,Homologous recombination WP186,0.7730226615281957,0.6930232558139535,0.17841669887760933,['POLD4'],0.9999288470839088,0,0,1
363,Leptin Insulin Overlap WP3935,0.7730226615281957,0.6930232558139535,0.17841669887760933,['LEPR'],0.9999288470839088,0,0,1
364,"NAD metabolism, sirtuins and aging WP3630",0.7730226615281957,0.6930232558139535,0.17841669887760933,['ROS1'],0.9999288470839088,0,0,1
365,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.7849658802173451,0.6928400954653938,0.16774699830640133,"['CDKN1A', 'MAPK3']",0.9999288470839088,0,0,2
366,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.7867012789269885,0.7166031909418425,0.17191788665656557,"['JUN', 'FADD', 'MAPK3']",0.9999288470839088,0,0,3
367,AGE/RAGE pathway WP2324,0.7875214123357299,0.7527482522934588,0.17980499929842933,"['JUN', 'PRKCD', 'CYCS', 'MAPK3', 'SOD1']",0.9999288470839088,0,0,5
368,Amino Acid metabolism WP3925,0.7957429034829502,0.7692665735753706,0.17576135814785313,"['LDHA', 'PKM', 'TDO2', 'GOT1', 'MDH2', 'ALDH1A1', 'ODC1']",0.9999288470839088,0,0,7
369,Cell Differentiation - Index expanded WP2023,0.8016613249858495,0.6299669322925137,0.13926619021507122,['MEF2D'],0.9999288470839088,0,0,1
370,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.8016613249858495,0.6299669322925137,0.13926619021507122,['LDHA'],0.9999288470839088,0,0,1
371,Serotonin and anxiety WP3947,0.8016613249858495,0.6299669322925137,0.13926619021507122,['FOS'],0.9999288470839088,0,0,1
372,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.8016613249858495,0.6299669322925137,0.13926619021507122,['MAPK3'],0.9999288470839088,0,0,1
373,Neural Crest Cell Migration in Cancer WP4565,0.8041523772217223,0.6926567164179105,0.1509759628478712,"['JUN', 'FOS', 'EPHB3']",0.9999288470839088,0,0,3
374,Cannabinoid receptor signaling WP3869,0.8056105638702032,0.6597908853278782,0.14261698310216087,"['PRKAR1A', 'MAPK3']",0.9999288470839088,0,0,2
375,Ethanol effects on histone modifications WP3996,0.8056105638702032,0.6597908853278782,0.14261698310216087,"['AHCY', 'ALDH1A1']",0.9999288470839088,0,0,2
376,Hematopoietic Stem Cell Differentiation WP2849,0.8056105638702032,0.6597908853278782,0.14261698310216087,"['FOS', 'ABO']",0.9999288470839088,0,0,2
377,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8056105638702032,0.6597908853278782,0.14261698310216087,"['LPL', 'NDRG1']",0.9999288470839088,0,0,2
378,Wnt signaling in kidney disease WP4150,0.8056105638702032,0.6597908853278782,0.14261698310216087,"['FZD1', 'WNT2']",0.9999288470839088,0,0,2
379,Nephrotic syndrome WP4758,0.8203857152332138,0.6702551757342321,0.13269756533726784,"['CUBN', 'TRPC6', 'ARHGDIA']",0.9999288470839088,0,0,3
380,Phosphodiesterases in neuronal function WP4222,0.8227506709903663,0.6924731182795699,0.1351029426826532,"['ADCY10', 'PDE10A', 'PDE6C', 'PDE5A']",0.9999288470839088,0,0,4
381,RANKL/RANK signaling pathway WP2018,0.8227506709903663,0.6924731182795699,0.1351029426826532,"['JUN', 'MITF', 'FOS', 'MAPK3']",0.9999288470839088,0,0,4
382,Cell migration and invasion through p75NTR WP4561,0.8244711843417407,0.6297461488392276,0.12154924811633921,"['JUN', 'EFNB3']",0.9999288470839088,0,0,2
383,Lung fibrosis WP3624,0.8244711843417407,0.6297461488392276,0.12154924811633921,"['CEBPB', 'FGF1']",0.9999288470839088,0,0,2
384,Neovascularisation processes WP4331,0.8244711843417407,0.6297461488392276,0.12154924811633921,"['JAG1', 'MAPK3']",0.9999288470839088,0,0,2
385,Sphingolipid pathway WP1422,0.8244711843417407,0.6297461488392276,0.12154924811633921,"['CERS4', 'SERINC1']",0.9999288470839088,0,0,2
386,Biomarkers for pyrimidine metabolism disorders WP4584,0.8266883821129146,0.5774199960246472,0.10989888128392024,['CKB'],0.9999288470839088,0,0,1
387,"GPCRs, Class B Secretin-like WP334",0.8266883821129146,0.5774199960246472,0.10989888128392024,['ADGRG2'],0.9999288470839088,0,0,1
388,IL-9 signaling pathway WP22,0.8266883821129146,0.5774199960246472,0.10989888128392024,['MAPK3'],0.9999288470839088,0,0,1
389,miRNA targets in ECM and membrane receptors WP2911,0.8266883821129146,0.5774199960246472,0.10989888128392024,['LAMA4'],0.9999288470839088,0,0,1
390,Phytochemical activity on NRF2 transcriptional activation WP3,0.8266883821129146,0.5774199960246472,0.10989888128392024,['CEBPB'],0.9999288470839088,0,0,1
391,IL-6 signaling pathway WP364,0.8354575061962654,0.6492537313432836,0.11672010412980699,"['BAD', 'PRKCD', 'MAPK3']",0.9999288470839088,0,0,3
392,Resistin as a regulator of inflammation WP4481,0.8416691565116198,0.6023139981321988,0.10381982047766024,"['PLCB2', 'MAPK3']",0.9999288470839088,0,0,2
393,16p11.2 proximal deletion syndrome WP4949,0.8445589846176571,0.7038966831562729,0.1189167980727488,"['TCP1', 'ALDOA', 'SEZ6L2', 'CCT7', 'CDIPT', 'MAPK3']",0.9999288470839088,0,0,6
394,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.8485590525625801,0.5329572037979909,0.08751988716086735,['BCL2L2'],0.9999288470839088,0,0,1
395,Riboflavin and CoQ disorders WP5037,0.8485590525625801,0.5329572037979909,0.08751988716086735,['RFK'],0.9999288470839088,0,0,1
396,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.8485590525625801,0.5329572037979909,0.08751988716086735,['NFKBIE'],0.9999288470839088,0,0,1
397,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8494257666715254,0.6295251017639077,0.10273517675613957,"['CXCL17', 'FADD', 'IFIT2']",0.9999288470839088,0,0,3
398,DNA damage response (only ATM dependent) WP710,0.8558716031599883,0.7188739404308266,0.11188188130740893,"['JUN', 'CDKN1A', 'CDKN1B', 'CDKN2A', 'BAD', 'BAX', 'WNT2', 'HRAS']",0.9999288470839088,0,0,8
399,Glycerophospholipid Biosynthetic Pathway WP2533,0.8573236542664529,0.5771678599840891,0.0888490888249685,"['PTPMT1', 'CDIPT']",0.9999288470839088,0,0,2
400,The influence of laminopathies on Wnt signaling WP4844,0.8573236542664529,0.5771678599840891,0.0888490888249685,"['CEBPA', 'CEBPB']",0.9999288470839088,0,0,2
401,Wnt signaling WP428,0.8594271857226061,0.7020095577585235,0.10634684858297425,"['FZD1', 'JUN', 'FRAT2', 'SFRP2', 'ROR1', 'WNT2', 'PLCB2']",0.9999288470839088,0,0,7
402,AMP-activated protein kinase (AMPK) signaling WP1403,0.8614877350123302,0.6655478412800588,0.09922949593157727,"['GYS2', 'CDKN1A', 'LEPR', 'EEF2', 'ACACB']",0.9999288470839088,0,0,5
403,Interleukin-11 Signaling Pathway WP2332,0.86234939732334,0.6109569798068482,0.0904795255365245,"['RPS6', 'HRAS', 'MAPK3']",0.9999288470839088,0,0,3
404,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.8676712081772117,0.49484623903228553,0.07023967690447469,['MAPK3'],0.9999288470839088,0,0,1
405,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.8676712081772117,0.49484623903228553,0.07023967690447469,['RARB'],0.9999288470839088,0,0,1
406,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.8676712081772117,0.49484623903228553,0.07023967690447469,['SUV39H1'],0.9999288470839088,0,0,1
407,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.871550246334478,0.5540334128878281,0.07616948908035286,"['JUN', 'FOS']",0.9999288470839088,0,0,2
408,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8735503714331873,0.6696635283222719,0.09053146742481497,"['FZD1', 'NRG1', 'CALM1', 'PLCB2', 'CALM2', 'MAPK3']",0.9999288470839088,0,0,6
409,MAPK Signaling Pathway WP382,0.8779285842176783,0.7806696516802628,0.10163540366661802,"['DUSP4', 'HSPA8', 'JUN', 'DUSP2', 'DUSP3', 'GADD45A', 'PRKCD', 'FOS', 'FGF1', 'ELK1', 'DUSP6', 'DUSP7', 'FGF17', 'NR4A1', 'DDIT3', 'STMN1', 'FLNB', 'HRAS', 'FGF10', 'MAPK3']",0.9999288470839088,0,0,20
410,Head and Neck Squamous Cell Carcinoma WP4674,0.8807753703221881,0.6407872307453898,0.08134964139567899,"['CDKN1A', 'CDKN2A', 'RPS6', 'FADD', 'HRAS']",0.9999288470839088,0,0,5
411,Joubert Syndrome WP4656,0.882149910635439,0.6589769879243563,0.08263127983925198,"['TMEM17', 'KAT5', 'CETN2', 'ANKS6', 'ARL2', 'ZNF423']",0.9999288470839088,0,0,6
412,PI3K-Akt signaling pathway WP4172,0.8836530885816106,0.7798975996262192,0.09646610115972967,"['CDKN1A', 'HSP90AA1', 'CDKN1B', 'LAMA2', 'FLT3', 'BAD', 'LAMA4', 'RPS6', 'LAMA3', 'FGF1', 'GYS2', 'FGF17', 'CREB3', 'GNG10', 'GNG3', 'CCNE2', 'PDGFD', 'COL6A6', 'HRAS', 'FGF10', 'MAPK3']",0.9999288470839088,0,0,21
413,Mesodermal commitment pathway WP2857,0.8843372680371104,0.6993826620259727,0.08596585373826392,"['VAV3', 'ARL4A', 'PRKAR1A', 'BHLHE40', 'RARB', 'RPL38', 'PLCH1', 'TOX', 'ZFHX4']",0.9999288470839088,0,0,9
414,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.8843725943191866,0.46181673623534086,0.056746571213391966,['PTGES'],0.9999288470839088,0,0,1
415,Kallmann's Syndrome WP5074,0.8843725943191866,0.46181673623534086,0.056746571213391966,['PRKCQ'],0.9999288470839088,0,0,1
416,Statin inhibition of cholesterol production WP430,0.8843725943191866,0.46181673623534086,0.056746571213391966,['LPL'],0.9999288470839088,0,0,1
417,Autophagy WP4923,0.8844599109871523,0.5326785386451257,0.06540125373771172,"['ATG101', 'ATG9A']",0.9999288470839088,0,0,2
418,Tumor suppressor activity of SMARCB1 WP4204,0.8844599109871523,0.5326785386451257,0.06540125373771172,"['H3F3B', 'CDKN2A']",0.9999288470839088,0,0,2
419,Regulation of toll-like receptor signaling pathway WP1449,0.8846151121044928,0.6725846133386528,0.08246064259250913,"['JUN', 'CUEDC2', 'PELI3', 'PELI2', 'FADD', 'FOS', 'MAPK3']",0.9999288470839088,0,0,7
420,Regulation of Microtubule Cytoskeleton WP2038,0.8852983005329872,0.5769154228855722,0.07028596828339416,"['PARD6A', 'CFL2', 'STMN1']",0.9999288470839088,0,0,3
421,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.8907555119511921,0.6018388655134799,0.06962390159961915,"['CDKN1A', 'CDKN1B', 'TRPC6', 'JAG1']",0.9999288470839088,0,0,4
422,Insulin Signaling WP481,0.894294927186382,0.7329909673659674,0.08188950314573165,"['EGR1', 'XBP1', 'JUN', 'GSK3A', 'PRKCH', 'PRKCD', 'FOS', 'ELK1', 'GYS2', 'RPS6KA2', 'PRKCQ', 'HRAS', 'ARF6', 'MAPK3']",0.9999288470839088,0,0,14
423,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.895439508128316,0.5612747075433643,0.06198752147633844,"['MAP1LC3A', 'ATG101', 'FTL']",0.9999288470839088,0,0,3
424,Ebstein-Barr virus LMP1 signaling WP262,0.8989671414330429,0.4329159212880143,0.04610935324629302,['HSP90AA1'],0.9999288470839088,0,0,1
425,Hippo-Yap signaling pathway WP4537,0.8989671414330429,0.4329159212880143,0.04610935324629302,['NDRG1'],0.9999288470839088,0,0,1
426,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.8989671414330429,0.4329159212880143,0.04610935324629302,['FLT3'],0.9999288470839088,0,0,1
427,PPAR signaling pathway WP3942,0.9047670186675372,0.5464571877454831,0.054688236620024706,"['FABP7', 'ACSL5', 'LPL']",0.9999288470839088,0,0,3
428,BDNF-TrkB Signaling WP3676,0.9067455859366873,0.4945448346403,0.04841265990324814,"['TRPC6', 'HRAS']",0.9999288470839088,0,0,2
429,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9076977629737456,0.5766626841895659,0.055846214854130896,"['LAMA2', 'CTNNA2', 'SGCG', 'ACTG1']",0.9999288470839088,0,0,4
430,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9117204829759858,0.4074152022168438,0.037654056053003,['MAP1LC3A'],0.9999288470839088,0,0,1
431,Monoamine Transport WP727,0.9117204829759858,0.4074152022168438,0.037654056053003,['TDO2'],0.9999288470839088,0,0,1
432,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9133350283236588,0.5323995407577498,0.04826335599214026,"['CEBPA', 'CDKN1A', 'CEBPB']",0.9999288470839088,0,0,3
433,Thermogenesis WP4321,0.9134699066238232,0.6507643536456499,0.058897328030189225,"['ADCY10', 'CREB3', 'RPS6KA2', 'RPS6', 'ZNF516', 'ACSL5', 'HRAS', 'ACTG1']",0.9999288470839088,0,0,8
434,Neural Crest Differentiation WP2064,0.9222649618366066,0.5535005973715651,0.04479077355503911,"['MITF', 'CDH7', 'RHOB', 'DLL3']",0.9999288470839088,0,0,4
435,DNA Repair Pathways Full Network WP4946,0.9222918594515461,0.6645452868474451,0.05375743080180191,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'CENPX', 'CETN2', 'RPA3', 'APEX1', 'POLE3', 'FANCF']",0.9999288470839088,0,0,10
436,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.9228647783156186,0.38474789637580337,0.0308846976650008,['FLT3'],0.9999288470839088,0,0,1
437,Monoamine GPCRs WP58,0.9228647783156186,0.38474789637580337,0.0308846976650008,['ADRA1D'],0.9999288470839088,0,0,1
438,Disruption of postsynaptic signaling by CNV WP4875,0.9249565784510775,0.4614956245027844,0.036000574403100304,"['YWHAG', 'MAPK3']",0.9999288470839088,0,0,2
439,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9249565784510775,0.4614956245027844,0.036000574403100304,"['MAP1LC3A', 'IGFBP5']",0.9999288470839088,0,0,2
440,Chemokine signaling pathway WP3929,0.925469803109708,0.6479928100659077,0.050189489410382516,"['SHC4', 'VAV3', 'GNG10', 'GNG3', 'PRKCD', 'HRAS', 'PLCB2', 'VAV2', 'MAPK3']",0.9999288470839088,0,0,9
441,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.925469803109708,0.6479928100659077,0.050189489410382516,"['FZD1', 'SPARC', 'JAG1', 'EIF5A2', 'WNT2', 'HRAS', 'MEF2D', 'DLL3', 'MAPK3']",0.9999288470839088,0,0,9
442,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9283989632229548,0.5063414634146342,0.03761799157455905,"['FOS', 'ELK1', 'MAPK3']",0.9999288470839088,0,0,3
443,EPO Receptor Signaling WP581,0.9326029290165027,0.3644666227285566,0.0254309333770788,['MAPK3'],0.9999288470839088,0,0,1
444,NRF2-ARE regulation WP4357,0.9326029290165027,0.3644666227285566,0.0254309333770788,['CEBPB'],0.9999288470839088,0,0,1
445,SARS-CoV-2 mitochondrial interactions WP5038,0.9326029290165027,0.3644666227285566,0.0254309333770788,['PHB'],0.9999288470839088,0,0,1
446,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.9327503640712149,0.4465701747632612,0.03108917798832138,"['GABRD', 'GABRG3']",0.9999288470839088,0,0,2
447,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9327503640712149,0.4465701747632612,0.03108917798832138,"['ACTA2', 'ACTG1']",0.9999288470839088,0,0,2
448,Notch Signaling WP268,0.9327503640712149,0.4465701747632612,0.03108917798832138,"['JAG1', 'DLL3']",0.9999288470839088,0,0,2
449,Toll-like Receptor Signaling Pathway WP75,0.9347328423739548,0.5321202095395644,0.03591519844625311,"['JUN', 'FADD', 'FOS', 'MAPK3']",0.9999288470839088,0,0,4
450,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.941112264051383,0.34621347644603456,0.021012680374305915,['HRAS'],0.9999288470839088,0,0,1
451,miRNA regulation of p53 pathway in prostate cancer WP3982,0.941112264051383,0.34621347644603456,0.021012680374305915,['BAX'],0.9999288470839088,0,0,1
452,Sphingolipid Metabolism (general overview) WP4725,0.941112264051383,0.34621347644603456,0.021012680374305915,['CERS4'],0.9999288470839088,0,0,1
453,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9424825965955781,0.7086424580095466,0.041978437901699604,"['CDKN1A', 'HSP90AA1', 'CDKN1B', 'LAMA2', 'BAD', 'LAMA4', 'RPS6', 'LAMA3', 'FGF1', 'GYS2', 'FGF17', 'CREB3', 'GNG10', 'GNG3', 'PDGFD', 'PELO', 'HRAS', 'FGF10', 'MAPK3']",0.9999288470839088,0,0,19
454,Integrated breast cancer pathway WP1984,0.9442969731831502,0.643874614907527,0.03690339802233807,"['PLK3', 'JUN', 'GSK3A', 'GADD45A', 'BAD', 'ODC1', 'BAX', 'PHB', 'FADD', 'FAU', 'JAKMIP1']",0.9999288470839088,0,0,11
455,Netrin-UNC5B signaling pathway WP4747,0.9460952466538208,0.4194329934186736,0.023241634214976197,"['JUN', 'MAPK3']",0.9999288470839088,0,0,2
456,Endoderm differentiation WP2853,0.9464675063323751,0.6008851861494402,0.03305988529518866,"['VAV3', 'DUSP4', 'DUSP2', 'TCEAL2', 'PLCH1', 'TOX', 'ZFHX4', 'NME1']",0.9999288470839088,0,0,8
457,p53 transcriptional gene network WP4963,0.9465282013575508,0.47169606512890094,0.02592182771512521,"['CDKN1A', 'GADD45A', 'BAX']",0.9999288470839088,0,0,3
458,Gastric Cancer Network 2 WP2363,0.9485477610463564,0.32969872504756226,0.01741572078422629,['S100A6'],0.9999288470839088,0,0,1
459,MTHFR deficiency WP4288,0.9485477610463564,0.32969872504756226,0.01741572078422629,['CYCS'],0.9999288470839088,0,0,1
460,Nanoparticle triggered autophagic cell death WP2509,0.9485477610463564,0.32969872504756226,0.01741572078422629,['MAP1LC3A'],0.9999288470839088,0,0,1
461,Sphingolipid Metabolism (integrated pathway) WP4726,0.9485477610463564,0.32969872504756226,0.01741572078422629,['CERS4'],0.9999288470839088,0,0,1
462,Regulation of Actin Cytoskeleton WP51,0.950312910701819,0.6222589495970791,0.031712785776794664,"['FGF17', 'CFL2', 'TMSB4X', 'CFL1', 'BRK1', 'PIP4K2C', 'FGF1', 'ACTG1', 'FGF10', 'MAPK3']",0.9999288470839088,0,0,10
463,IL-1 signaling pathway WP195,0.9515534997345583,0.4611741293532338,0.02290161538453853,"['JUN', 'PELI2', 'MAPK3']",0.9999288470839088,0,0,3
464,Ras signaling WP4223,0.9546011846764685,0.6372887616585096,0.02960947680926956,"['SHC4', 'GNG10', 'GNG3', 'FLT3', 'BAD', 'CALM3', 'CALM1', 'ELK1', 'CALM2', 'HRAS', 'ARF6', 'MAPK3']",0.9999288470839088,0,0,12
465,Signal transduction through IL1R WP4496,0.9550448621762501,0.3146853146853147,0.014474568934813805,['JUN'],0.9999288470839088,0,0,1
466,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9561349921913966,0.45110966904607397,0.02023505230928472,"['KAT5', 'CDKN2A', 'BAX']",0.9999288470839088,0,0,3
467,One-carbon metabolism and related pathways WP3940,0.956892036681055,0.39539720422775315,0.01742306243868597,"['GPX4', 'SOD1']",0.9999288470839088,0,0,2
468,mRNA Processing WP411,0.9644568632484639,0.5951790291904407,0.021539631500731293,"['SF3B5', 'LSM7', 'SF3A1', 'NCBP2', 'CD2BP2', 'CSTF2T', 'SNRPE', 'SNU13', 'SRSF9', 'LSM2']",0.9999288470839088,0,0,10
469,Lipid Metabolism Pathway WP3965,0.9700167347158297,0.2768515205724508,0.008427901627615525,['PRKAR1A'],0.9999288470839088,0,0,1
470,Nanoparticle-mediated activation of receptor signaling WP2643,0.9700167347158297,0.2768515205724508,0.008427901627615525,['HRAS'],0.9999288470839088,0,0,1
471,Pathways affected in adenoid cystic carcinoma WP3651,0.9706974750033225,0.4148776119402985,0.012338634211771974,"['CEBPA', 'CNTN6', 'HRAS']",0.9999288470839088,0,0,3
472,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9706974750033225,0.4148776119402985,0.012338634211771974,"['DUSP2', 'STMN1', 'MAPK3']",0.9999288470839088,0,0,3
473,ATM Signaling Network in Development and Disease  WP3878,0.972600619564713,0.3547212532892724,0.009854775047978596,"['KAT5', 'CDK5R1']",0.9999288470839088,0,0,2
474,Splicing factor NOVA regulated synaptic proteins WP4148,0.972600619564713,0.3547212532892724,0.009854775047978596,"['CAV2', 'NCDN']",0.9999288470839088,0,0,2
475,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9771128627859803,0.2562998299432408,0.005934139147856671,['SUPT4H1'],0.9999288470839088,0,0,1
476,Hippo-Merlin Signaling Dysregulation WP4541,0.9773278642228775,0.4667937513125798,0.010705028063622958,"['PRKAR1A', 'FLT3', 'HRAS', 'CDH18', 'CDH7']",0.9999288470839088,0,0,5
477,Integrin-mediated Cell Adhesion WP185,0.979266504396317,0.4605299860529986,0.009648772108702526,"['VAV3', 'CAPNS1', 'CAV2', 'HRAS', 'VAV2']",0.9999288470839088,0,0,5
478,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9827088595169955,0.32161292113004386,0.005609694194551381,"['HRAS', 'MAPK3']",0.9999288470839088,0,0,2
479,Wnt Signaling Pathway WP363,0.9827088595169955,0.32161292113004386,0.005609694194551381,"['GSK3A', 'ROR1']",0.9999288470839088,0,0,2
480,Fragile X Syndrome  WP4549,0.9838493845938425,0.5111554668440896,0.008322867462576634,"['GRIP1', 'DUSP3', 'PRKAR1A', 'CDKN2A', 'CLTCL1', 'AKAP5', 'GABRD', 'AP2M1']",0.9999288470839088,0,0,8
481,Target Of Rapamycin (TOR) Signaling WP1471,0.9847372871255509,0.2306102166567283,0.0035468743697005317,['RRAGA'],0.9999288470839088,0,0,1
482,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9862959414940927,0.30726597719437815,0.004239909727498876,"['TKFC', 'FADD']",0.9999288470839088,0,0,2
483,Hedgehog Signaling Pathway WP4249,0.9866656613369972,0.22315194183161174,0.00299560042538492,['EVC'],0.9999288470839088,0,0,1
484,TGF-beta Signaling Pathway WP366,0.9882517805461604,0.47353351873364546,0.005596112622272657,"['KLF10', 'JUN', 'CDKN1A', 'PARD6A', 'CITED1', 'FOS', 'SKP1']",0.9999288470839088,0,0,7
485,Allograft Rejection WP2328,0.9883504795422597,0.216159809183065,0.002532940705326329,['HLA-DQB1'],0.9999288470839088,0,0,1
486,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9907398060221327,0.33974064105701,0.0031607213763769296,"['GSK3A', 'RBP4', 'LPL']",0.9999288470839088,0,0,3
487,Ectoderm Differentiation WP2858,0.9953242337661506,0.4056431184914157,0.0019011405125507572,"['ARHGDIG', 'CTNNA2', 'JAKMIP1', 'CELSR2', 'ZFHX4', 'LY6E']",0.9999288470839088,0,0,6
488,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9965465840744678,0.16857919920880782,0.0005831816562630736,['DHCR24'],0.9999288470839088,0,0,1
489,Energy Metabolism WP1541,0.9965465840744678,0.16857919920880782,0.0005831816562630736,['MEF2D'],0.9999288470839088,0,0,1
490,Interferon type I signaling pathways WP585,0.9973642491947248,0.16071057120272914,0.00042415224315145705,['RPS6'],0.9999288470839088,0,0,1
491,MECP2 and Associated Rett Syndrome WP3584,0.9973991283562331,0.23407224626835485,0.0006095849380795481,"['RPS6', 'FKBP5']",0.9999288470839088,0,0,2
492,Rett syndrome causing genes WP4312,0.998242398236317,0.15019055767286305,0.0002642074428629825,['GABRD'],0.9999288470839088,0,0,1
493,Ciliopathies WP4803,0.9988599567304394,0.41277411623726784,0.00047084879809264406,"['DNAH11', 'TMEM17', 'EVC', 'ANKS6', 'PKD1L1', 'CCDC65', 'CCNQ', 'ZNF423', 'CCNO']",0.9999288470839088,0,0,9
494,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9992244277542213,0.315946193455694,0.0002451341707256971,"['GSK3A', 'RPS6KA2', 'LPL', 'HRAS', 'MAPK3']",0.9999288470839088,0,0,5
495,Genes related to primary cilium development (based on CRISPR) WP4536,0.9998364398898921,0.21298661332512694,3.483896313695813e-05,"['TMEM17', 'EVC', 'DYNLL1']",0.9999288470839088,0,0,3
496,DNA IR-damage and cellular response via ATR WP4016,0.9999288470839088,0.09849220546894966,7.008256963282748e-06,['FEN1'],0.9999288470839088,0,0,1
